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INTEGRATING p300 FUNCTIONS IN HTLV-1 TRANSCRIPTION INITIATION 
 
 
 The HTLV-1 provirus overcomes a repressive chromatin environment for efficient 
transcription of its genome. This is accomplished by the robust recruitment of the 
coactivator protein, p300, to the viral enhancer sites through interactions with DNA 
bound pCREB and the viral transactivating protein, Tax. Recruitment of p300 to the 
HTLV-1 promoter results in histone acetylation and nucleosome depletion from the 
promoter region in the presence of the histone chaperone, Nap1.  
  To study the histone acetylation requirements for Nap1-dependent nucleosome 
disassembly, we utilized immobilized in vitro assembled chromatin templates containing 
site specific K→R mutations within the N-terminal tails of the histones. Through these 
studies, we identified histone H3, lysine 14 as the functionally relevant acetylation site 
for Nap1-dependent nucleosome disassembly. Additionally, we found a significant 
correlation between nucleosome disassembly from the HTLV-1 promoter and 
acetylation-dependent transcription activation. These studies suggest that nucleosome 
disassembly is a prerequisite for transcription activation, as nucleosome disassembly 
creates a nucleosome free region within the HTLV-1 promoter, allowing for the 
subsequent recruitment of Pol II and general transcription machinery for activation of 
transcription.  
 The identification of a single and specific acetyl-lysine residue led us to the 
hypothesis that the p300 acetyl-lysine binding domain (bromodomain) was involved in 
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HTLV-1 transcription activation through recognition of H3K14ac. To test this hypothesis, 
we utilized a p300 bromodomain deletion mutant and a CBP/p300 specific 
bromodomain inhibitor, (SGC-CBP30), to investigate the involvement of the p300 
bromodomain in HTLV-1 transcription activation. Importantly, we found that the p300 
bromodomain is not involved in the initial recruitment of the coactivator to the chromatin 
template as previously proposed, rather the bromodomain functions after recruitment to 
the promoter and following acetylation of the histone tails. These findings are consistent 
with a role for the p300 bromodomain in nucleosome disassembly and uncover a novel 
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1.1a DISCOVERY OF HTLV-1 
 During the late 1970’s, Japanese clinicians identified a cluster of leukemias in 
southwestern Japan termed adult T-cell leukemia (ATL), hypothesizing that the 
clustering was due to an infectious agent (2, 3). Between 1980 and 1982, researchers in 
the USA and Japan independently isolated a virus shown to be the causative agent of 
ATL (4-6). This was the first identification of a human oncogenic retrovirus. The virus 
was eventually named human T-cell leukemia virus (HTLV-1) and was different from 
previously known transforming retroviruses from other animal hosts in that HTLV-1 did 
not carry viral homologues of cellular proto-oncogenes (9). Rather, HTLV-1 encoded for 
accessory proteins, namely the viral encoded oncoprotein, Tax, which contributes to 
HTLV-1’s transforming capabilities. In addition to causing ATL, HTLV-1 infection has 
also been demonstrated to cause a progressive neurological disorder termed HTLV-1 
associated myelopathy/tropical spastic paraparesis (HAM/TSP) (10, 11). 
 
1.1b PREVALANCE AND TRANSMISSION OF HTLV-1 INFECTION 
 It is currently estimated that 5-10 million people are infected with HTLV-1 
worldwide (13). Endemic regions include southwestern Japan, Africa, the Caribbean 
Islands, and South America.  
 Initial transmission of the virus requires cell-cell contact and is therefore 
transmitted from an infected individual to an uninfected individual through exposure to 
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contaminated blood products, through sexual contact, or from mother to child through 
breast feeding. CD4+ T cells are the primary infected cell type in vivo, although it has 
been demonstrated that CD8+ T cells, B lymphocytes, monocytes, dendritic cells, 
macrophages and astrocytes may also be infected with HTLV-1 in vivo (14-16). It has 
been reported that the glucose transporter 1 protein (GLUT1), the surface heparin 
proteoglycan -1 and the neuropilin-1 proteins are involved in binding and entry of the 
virus [reviewed in (17)], however, how these proteins are involved in tropism of the virus 
is not understood, as many cell types express these proteins on their cell surface.  
 
1.1c HTLV-1 ASSOCIATED DISEASES 
 Most infected individuals remain asymptomatic carriers throughout their lifetime, 
however, 1-5% develop ATL (18) and up to 4% develop HAM/TSP (19). A large part of 
current HTLV-1 research efforts are focused on the molecular basis of HTLV-1 
dependent malignant transformation of T cells and why only a small percentage of 
infected individuals develop the leukemia. 
 It is well established that HTLV-1 is the etiological agent of ATL. HTLV-1 infection 
was first linked to adult T-cell leukemia in 1980 when a retrovirus was isolated from a 
cell line derived from a patient mistakenly diagnosed with cutaneous T-cell lymphoma 
(later to be recognized as ATL) (4). Shortly thereafter, a retrovirus was successfully 
isolated from cells derived from ATL patients (5). Adding to the evidence that HTLV-1 
causes ATL, leukemic cells taken directly from numerous ATL patients tested positive 
for the integrated HTLV-1 provirus (20). To date, the monoclonal integration of the 
HTLV-1 provirus has been detected in all cases of ATL examined (21). 
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 A diagnostic feature of ATL is the presence of morphologically abnormal 
lymphocytes in the peripheral blood. Leukemic cells have a characteristic “flower” shape 
due to a multilobulated nucleus and very little cytoplasm. Accompanying abnormal 
lymphocyte morphology, patients with ATL might also develop hypercalcemia, as well 
as skin lesions from infiltration of leukemic cells into the epidermis. ATL patients are 
also at an increased risk of opportunistic infections due to weakening of the immune 
system.  
 There are four subtypes of ATL: smoldering, chronic, lymphoma-type and acute. 
The latter two subtypes are aggressive, as it has been recently reported that median 
survival time from diagnosis is approximately 13 months, despite modern ATL 
treatments that include multi-drug chemotherapy, a combination of azidothymidine 
(AZT) and IFN-α therapy, and allogeneic hematopoietic stem cell transplantation (22, 
23). 
 The mechanism by which HTLV-1 infection leads to malignant transformation of 
T cells is still not completely understood. However, the main theory postulates that the 
virally encoded regulatory protein, Tax (discussed below), mediates disruption of normal 
cellular functions such as DNA repair, cell cycle, and apoptosis, leading to cell 
proliferation and accumulation of genetic mutations. However, ATL cells express very 
little Tax protein and the clinical latency is long; typically 40-60 years after infection with 
the virus.  A current hypothesis accommodating these two observations proposes 
cycles of transient Tax expression, allowing for infected cells not expressing Tax to i) 
replicate by clonal expansion ii) evade the immune system iii) and slowly accumulate 
mutations, thus increasing the likelihood of malignant transformation (24).  
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 As mentioned, another disease caused by HTLV-1 infection is HAM/TSP and 
was first described in 1986 (11). HAM/TSP is a progressive, chronic and incapacitating 
neuroinflammatory disorder. The disease manifests itself as muscle weakness, stiffness 
and spasms in the lower extremities, similar to the symptoms of multiple sclerosis. 
HAM/TSP patients also frequently become incontinent and incur sensory disturbance as 
a result of loss of nervous function.   
 The myelopathy results from chronic inflammation and subsequent demyelination 
of the spinal cord. Although the exact mechanism by which HTLV-1 infection induces 
disease is unknown, the current understanding is that overactivated, infected CD4+ T 
cells migrate across the blood-brain barrier from the peripheral blood to the central 
nervous system and begin to express Tax and secrete proinflammatory cytokines.  The 
cytokines stimulate the production of chemokines that recruit more HTLV-1 infected 
CD4+ T cells and HTLV-1 specific CD8+ T cells to the site of inflammation, thereby 
ultimately causing damage to the nearby nervous tissue [reviewed in (25)].  
 
1.1d THE HTLV-1 GENOME AND VIRAL LIFE CYCLE 
 HTLV-1 is a member of the Retroviridae family of viruses, specifically of the 
Deltaretrovirus genus. In addition to HTLV-1, Deltaretrovirus genus members include 
Simian T-cell leukemia virus, Bovine leukemia virus and HTLV-2, 3 and 4 (26).  
 The HTLV-1 viral life cycle can be divided into two phases: the establishment 
phase, which primarily depends on viral proteins carried with the virion and the 








During the establishment phase, the virus gains entry into the host cell via interaction of 
its surface glycoprotein (gp46) and transmembrane protein (gp21) with a cellular 
receptor. This interaction results in membrane fusion and subsequent uncoating of the 
virus. Contained in the HTLV-1 virion core are two copies of the (+) sense single 
stranded RNA (+ssRNA) genome, as well as viral proteins required to carry out reverse 
transcription and provirus integration once the viral genome has entered the host cell 
cytoplasm (27). Viral reverse transcriptase uses two enzymatic activities to produce a 
DNA provirus from the ssRNA genome: RNA dependent DNA polymerase activity and 
RNase H activity. Upon reverse transcription, the double stranded DNA molecule 
translocates to the nucleus where it is randomly integrated into the host cell genome by 
the viral integrase. Importantly, the U3 region of the LTR contains the HTLV-1 promoter 
that is critical for driving expression of the HTLV-1 provirus.  
 The protein encoding region of HTLV-1 is found between the LTRs. The gag 
gene encodes for structural proteins including capsid (CA), nucleocapsid (NA) and 
matrix (MA) proteins. The pro gene encodes for a protease that is responsible for 
processing the gag/pro/pol polyprotein. Reverse transcriptase (RT) and integrase (IN) 
are encoded for by the pol gene. The env gene encodes for envelope glycoproteins that 
are involved in receptor recognition during viral entry. HTLV-1 is considered a complex 
retrovirus and as such encodes for unique regulatory and accessory proteins in the pX 
region near the 3’ end of the provirus in addition to the prototypical env, prot, pol and 
gag gene products just mentioned. Regulatory proteins include Tax, which is 
responsible for transactivation of the provirus as well as deregulation of numerous other 
cellular functions, and Rex, which is involved in the nuclear export of unspliced mRNAs 
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encoding gag/pol/env (28, 29). Accessory proteins, p12, p13 and p30 are involved in 
various mechanisms that fine tune expression of the provirus and regulate cell growth, 
allowing for replication and viral persistence [reviewed in (30)]. In addition, an antisense 
transcript is made from the 3’ LTR and codes for a regulatory protein called HTLV-1 
basic leucine zipper factor (HBZ). HBZ promotes proliferation of T cells while 
downregulating expression of the provirus, again regulating viral replication and 
persistence (31) (Figure 1.2). 
 During the expression and replication phase, the host cell transcription 
machinery navigates the chromatin environment to express the HTLV-1 provirus in the 
form of a cellular messenger RNA. The messenger RNA is either spliced and 
subsequently translated to create viral gene products necessary for virion production 
and release, or remains unspliced, serving as the genome for progeny viruses. Once 
gene products are made, they are packaged into virions at the cell surface where virions 
either bud from the host cell membrane or are transferred from an infected cell to an 
uninfected cell through the formation of a viral synapse.  
 
1.2 TAX-MEDIATED TRANSCRIPTION ACTIVATION OF THE HTLV-1 PROVIRUS 
 Upon initial infection and during periods of reactivation, HTLV-1 must overcome 
the repressive nature of its chromatin environment to express viral genes that are 
needed for viral persistence. HTLV-1 accomplishes this through the use of a series of 
Tax-responsive enhancer elements located within the U3 region of the LTRs of the 
provirus. These enhancer elements serve as binding sites for the recruitment of viral 




Figure 1.2. Schematic of the HTLV-1 genome. Open reading frames corresponding to their 




initiation of HTLV-1 transcription. Understanding Tax-mediated transcription activation 
of the HTLV-1 provirus provides insight into inhibiting viral replication, and serves as an 
outstanding model system for studying general cellular mechanisms of gene activation. 
 
1.2a CREB/TAX PROTEIN-PROTEIN AND PROTEIN-DNA INTERACTIONS AT THE 
HTLV-1 PROMOTER ARE REQUIRED FOR TRANSCRIPTION ACTIVATION 
 Found within the U3 region of the 5’ and 3’ LTRs of the HTLV-1 provirus is a 
series of Tax-responsive enhancer elements (32-34). These enhancer elements, termed 
viral CREs (vCREs), are off-consensus cellular cAMP response elements (CRE) flanked 
by short sequences of GC-rich DNA. There are three vCREs located at approximately -
100, -200 and -250 bp upstream from the transcription start site (tss) (33). The vCREs 
serve as binding sites for the viral transactivator protein, Tax, as well as for cellular 
transcription factors, namely the ATF/CREB family members (35-39) (Figure 1.3A).  
The vCREs differ from cellular CREs by 0-2 base pairs within one of the half sites of the 
vCRE, thereby resulting in 10-fold reduced affinity for CREB. It has been demonstrated 
that Tax enhances CREB binding to the vCREs not only through protein-protein 
interactions that promote CREB dimerization through its bZIP domain, but also through 
an interaction with the minor groove of the GC-rich flanking sequence of the vCREs (35, 
40-46). Most importantly, the stable Tax/CREB/vCRE complex is required for 
transcription from the HTLV-1 promoter (35, 47). Furthermore, phosphorylation of CREB 
at Ser133 significantly enhances recruitment of the coactivator CREB binding protein 




Figure 1.3. The HTLV-1 enhancer elements. A) Location of the viral enhancer elements within the 
integrated HTLV-1 provirus. Adapted from Nyborg et al. 2009 (7). B) Illustration of the protein-protein and 




1.2b CBP/P300 COACTIVATOR RECRUITMENT  
 CBP and p300 were first identified as coactivator proteins independently from 
each other through interactions with their binding partners, CREB and viral oncoprotein 
E1A, respectively (50-53). Soon after their characterization, it was realized that CBP 
and p300 share high amino acid sequence homology and therefore, functional domains 
(51). CBP/p300 are large, multidomain cellular coactivator proteins that are involved in 
several cellular processes, including cell growth, development, differentiation and 
transformation (54). They are frequently considered functionally homologous in the 
literature, although subtle differences do arise during particular cellular processes (55, 
56). 
 The coactivator proteins bind numerous cellular transcription factors to promote 
gene activation, serving as adaptor molecules that simultaneously interact with and 
recruit components of the basal transcription machinery (57). It is not surprising then 
that the CBP/p300 interactome includes over 400 different proteins (58). In addition to 
transcription factor binding and recruitment of basal transcription machinery, CBP and 
p300 function as coactivators through their intrinsic acetyltransferase activity, capable of 
acetylating histone proteins as well as non-histone proteins (59-62). 
 The major defined CBP/p300 domains involved in protein binding are the 
cysteine-histidine rich regions, CH1 and CH3, the KIX domain, and the interferon 
binding domain (iBiD) (54).  Acetyltransferase activity is located within the core domain, 
which is comprised of a bromodomain, RING domain, PHD domain and HAT domain. 
The bromodomain specifically recognizes acetylated lysine residues and is involved in 
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coactivator targeting (63, 64), while the RING domain negatively regulates p300 HAT 
activity, possibly by sterically occluding the HAT active site (65) (Figure 1.4).  
 Tax interaction with CBP/p300 occurs through multiple domains on the 
coactivators. First, Tax interacts with a carboxy-terminal region of CBP through an 
amphipathic helix of Tax (aa 312-319). Interestingly, this region of CBP, found within the 
iBiD binding domain, is the steroid receptor coactivator (SRC-1) interaction domain. Tax 
competes with SRC-1 for binding with CBP and importantly, point mutagenesis within 
the corresponding Tax and CBP interacting domains decreased Tax activation of the 
HTLV-1 promoter in vitro and in vivo (66). Second, it has been well demonstrated that 
Tax directly interacts with CBP through an interaction with the KIX domain (67-70). The 
minimal KIX domain required for interaction with Tax is aa 588-683, which is a similar 
region to that required for pCREB interaction. Since both pCREB and Tax bind KIX 
simultaneously, this observation suggests that Tax and pCREB bind the hydrophobic 
core of the KIX domain, albeit at different surfaces (70, 71). Notably, disruption of the 
Tax/KIX or pCREB/KIX interaction inhibits Tax transcriptional activation of HTLV-1 in 
vitro and in vivo (72). Lastly, the CH1 domain of CBP has also been implicated in an 
interaction with Tax, where Tax and p73 binding is mutually exclusive (73). The 
functional consequence of robust recruitment of CBP/p300 to the HTLV-1 promoter and 
its role in mediating chromatin remodeling at the HTLV-1 promoter for subsequent 




Figure 1.4. p300 domains. Domains known to interact with Tax and pCREB are indicated. Also indicated is the p300 




1.3 OVERCOMING REPRESSIVE CHROMATIN STRUCTURE DURING 
TRANSCRIPTION ACTIVATION THROUGH HISTONE ACETYLATION 
 DNA exists in the nucleus of a cell as a nucleoprotein complex, called chromatin, 
which is inhibitory to many processes requiring access to the genetic material. 
Therefore, cellular mechanisms exist to modulate chromatin structure and gain access 
to the DNA. Mechanisms involved in chromatin structure regulation in the context of 
transcription activation and histone acetylation are discussed below.  
 
1.3a CHROMATIN STRUCTURE REGULATION 
The most basic unit of chromatin is the nucleosome, which is comprised of 
approximately 146 bp of DNA wrapped 1.65 times around an octamer of the core 
histone proteins, H2A, H2B, H3 and H4 (74, 75). Two H2A/H2B dimers and a H3/H4 
tetramer comprise the octameric protein component of the nucleosome. The histone 
proteins have an unstructured N-terminal “tail” and a structured histone fold domain. 
The fold domains are held within the nucleosome and make up its core, while the highly 
basic tails extend past the gyres of the wrapped DNA. 
 Chromatin is composed of arrays of nucleosomes that are capable of taking on 
various structural forms (Figure 1.5). Chromatin folding and compaction is mediated by 
intra-nucleosomal contacts of the N-terminal histone tails with neighboring nucleosomes 
and linker DNA, as well as by linker histone H1 binding [reviewed in (76)]. These 
interactions lead to more compact and folded chromatin states (i.e. more repressive), 
going from an extended, 10 nm “beads on a string” structure to a compacted 30 nm 




Figure 1.5. Chromatin structure hierarchy. Nuclosomes are the most basic unit of chromatin. Chromatin 
consists of nucleosome arrays where histone tails interact with linker DNA and neighboring nucleosomes to 
form higher ordered chromatin structures as seen in the electron micrographs taken from Olins et al. 2003 (7). 
The nucleosome core particle was taken from Hansen et al. 2010 (12). 
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erythrocytes at low and moderate ionic strength (7, 77). It should be noted that the exact 
structure of 30 nm and larger chromatin fibers in vivo is unknown and that their 
existence in vivo remains controversial [reviewed in (78, 79)]. 
 It is well established that chromatin is generally repressive to transcription (80-
84). Therefore, eukaryotic cells have developed mechanisms for the decompaction and 
movement of nucleosomes at promoter regions allowing for the binding of 
transcriptional activators and transcription machinery and subsequent gene activation. 
Thus, the dynamic regulation of chromatin structure is essential to controlling which 
genes are actively transcribed. 
 Chromatin structure and fluidity is regulated by numerous mechanisms; however, 
three major modes of regulation are generally recognized: i) Chromatin remodeling 
complexes use the energy from ATP hydrolysis to alter nucleosome occupancy and 
positioning and thus chromatin structure (85). ii) Histone chaperones exchange 
canonical histones with histone variants. Upon incorporation into nucleosomes, these 
variants may create less stable octamers and facilitate in the removal of nucleosomes 
from promoter regions, activating transcription (86, 87). iii) Perhaps the most studied, 
but least understood due to complexity and an overwhelming number of combinatorial 
scenarios, is regulation through covalent post-translational modifications of the histone 
tails (88). These include acetylation, methylation, phosphorylation, ubiquitination, 
sumoylation, ADP ribosylation, deimination and proline isomerization (89). These 
modifications occur in various combinations to keep DNA either compact or open via the 
loss, sliding, or exchange of a nucleosome (90-92). An important consequence of 
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post-translational modification of the histone tails is that the N-terminal histone tails 
themselves become important regulators of chromatin dynamics.  
 
1.3b CHROMATIN STRUCTURE REGULATION THROUGH HISTONE 
ACETYLATION 
As just mentioned, N-terminal histone tails are sites of numerous post-
translational modifications (PTMs) that affect compaction of the chromatin fiber. Of 
these modifications, acetylation was the first identified and is perhaps the best studied 
and most directly associated with gene activation (93). Histone acetyltransferases 
(HATs) and histone deacetylases (HDACs) are the enzymes responsible for the addition 
and removal of an acetyl moiety to the ε-amino group of lysine residues. Together, 
HATs and HDACs help regulate chromatin dynamics and therefore, gene regulation.  
The addition of an acetyl group onto a lysine residue sidechain acts in two ways; 
through charge neutralization of the positively charged lysine residue and through 
creation of a new binding site for an additional protein. At physiological pH, the 
positively charged lysine residue is neutralized upon acetylation, leading to the 
disruption of histone tail contacts with linker DNA and acidic patches on other 
nucleosomal histones (94). Studies have shown that chromatin decompaction and 
transcription activation occur as a result of both global and residue specific tail 
acetylation. For example, the H4 tail is acetylated at lysines 5, 8, 12 and 16. Acetylation 
of lysines 5, 8 and 12 appear to contribute to the cumulative nature of the charge 
neutralization model, whereas K16 acetylation appears to possess a unique function in 
transcription (95). This is further corroborated in vitro where specific acetylation of 
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H4K16 reduces 30 nm fiber compaction (94, 96). Importantly, while acetylation of 
histone tails results in decompaction of the chromatin fiber, it does not result in the 
destabilization of a nucleosome, per se (83).  
The addition of an acetyl group can also create an epitope for the 
binding/recruitment of other protein to chromatin. In particular, proteins containing 
bromodomains, which recognize acetylated lysines, are directly recruited and act on the 
chromatin fiber (97).  Indeed, many chromatin modifying complexes, including HATs 
and ATP-dependent remodelers, contain at least one bromodomain, further contributing 
to the specificity of their substrate binding (98). As a consequence, upon substrate 
binding through acetyl-lysine recognition, these complexes can act on the chromatin 
through ATP-dependent nucleosome remodeling, histone exchange, or further 
post-translational modification.  
 Histone tail acetylation has long been correlated with actively transcribed genes. 
Recently, chromatin immunoprecipitation (ChIP) assays in yeast and higher eukaryotes 
have shown genome-wide that H3 and H4 acetylation corresponds to active gene 
regions (99-102). Additionally, ChIP-seq data has demonstrated that CBP/p300 
occupancy at promoter regions positively correlates with DNase1 hypersensitive sites 
(103). However, the relative contribution of charge neutralization versus targeted 
histone tail acetylation for gene activation is unknown. Thus, while histone acetylation is 
known to favor a more relaxed chromatin state, and is associated with an increase in 
transcription, the precise mechanism by which acetylation promotes a transcriptionally 




1.4 ACETYLATION-DEPENDENT CHROMATIN REMODELING OF THE HTLV-1 
PROMOTER FACILITATES TRANSCRIPTION ACTIVATION 
There have been numerous studies focused on the mechanism of Tax 
transactivation of the HTLV-1 provirus in a chromatin environment. Summarized below 
are the studies that contributed to the foundation of the research presented herein. 
In vitro studies utilizing recombinant chromatin templates have demonstrated that 
the pCREB/Tax/vCRE recruited HAT activity of p300 through the p300-KIX domain is 
required for transcription activation of the HTLV-1 gene (72, 104, 105). Additionally, 
chromatin templates lacking N-terminal histone tails have reduced dependence on 
Ac-CoA and p300 for transcription activation, suggesting that the N-terminal histone 
tails are the main targets of p300 HAT activity (104). 
Tax-dependent p300 recruitment to an integrated HTLV-1 promoter driving a 
luciferase gene was correlated with decreased acetylated H3 at the promoter and 
coding region of the gene. This loss in acetylated histones was found to be due to a loss 
of histones at the HTLV-1 promoter and not a decrease in acetylation itself. Adding to 
the evidence that nucleosomes were depleted from the HTLV-1 promoter upon Tax 
activation, chromatin isolated from cells transiently transfected with Tax showed 
increased sensitivity to micrococcal nuclease digestion than chromatin isolated from 
cells not expressing Tax. The above observations positively correlated with an increase 
in Pol II recruitment and strong activation of transcription. These data suggest a 
mechanism by which Tax regulates the removal of histones from the promoter for 
subsequent Pol II recruitment and gene activation (106).  
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To study the loss of nucleosome occupancy at the HTLV-1 promoter in vitro, an 
immobilized template assay was developed using the full HTLV-1 viral promoter linked 
to a streptavidin coated magnetic bead via a 5’ biotin moiety. The immobilized promoter 
was then assembled into chromatin using the method of salt deposition. In vitro 
nucleosome disassembly was found to be dependent upon binding of Tax, together with 
the cellular transcription factor pCREB to the vCREs, and their subsequent recruitment 
of the cellular coactivator and HAT, p300. In the presence of Ac-CoA, acceptor DNA 
and the nucleosome assembly protein, Nap1, the nucleosome octamer was 
disassembled from the promoter. Importantly, nucleosome disassembly was 
independent of transcription and ATP-dependent chromatin remodeling.  Nap1 is a 
highly conserved histone chaperone that transports histones H2A/H2B from the 
cytoplasm to the nucleus and is predominately thought to have a role in nucleosome 
assembly. This study, however, presents a novel functional role of Nap1 in 
acetylation-dependent nucleosome disassembly (107).  
Together, these studies demonstrated that HTLV-1 enhancer elements recruit 
cellular transcription factor pCREB, and that the DNA-bound pCREB/Tax complex 
strongly recruits cellular coactivator proteins CBP/p300 to initiate HTLV-1 transcription 
activation. Transcription activation requires the HAT activity of CBP/p300 that is 
tethered to the vCRE through interactions with pCREB and Tax within the p300 KIX 
domain. In the presence of Nap1, nucleosomes are disassembled from the promoter in 
an Ac-CoA dependent mechanism, creating a more permissive substrate for the 




Based on these observations, my thesis work sought out to identify the precise 
acetylation requirements for nucleosome disassembly and transcription activation. 
Using chromatin templates assembled from histones containing K→R mutations within 
the histone tails, coupled with nucleosome disassembly and in vitro transcription 
assays, we discovered that acetylation of only a single lysine residue on histone H3, 
lysine 14, was required for nucleosome disassembly and transcriptional activation (1). 
Furthermore, this study directly linked nucleosome disassembly with transcription 
activation, as chromatin templates permissive to nucleosome disassembly were 
permissive to transcription activation. Moreover, chromatin templates that carried a 
mutation in H3-K14 were refractory to nucleosome disassembly and transcription 
activation.  
In considering potential mechanisms for these observations, we hypothesized 
that, following acetylation of H3-K14 by p300, the acetylated lysine-binding 
bromodomain of p300 recognizes the K14 acetylated H3 tail and leverages the 
nucleosome open, creating a “destabilized” nucleosome that is disassembled by the 
histone chaperone, Nap1. Significantly, we have found that a p300 carrying a deletion of 
the bromodomain is defective for transcription activation. Importantly, the transcription 
defect is not a consequence of a defect in promoter recruitment, or acetylation activity, 
as previously proposed (63). Rather, our research demonstrates that deletion of the 
bromodomain produces a block in transcriptional activation at a step following p300 
recruitment to the promoter, and acetylation of the neighboring histone tails. These data 
support a possible role of the p300 bromodomain in facilitating the depletion of 




NUCLEOSOME EVICTION AND ACTIVATED TRANSCRIPTION REQUIRE p300 






Histone posttranslational modifications and chromatin dynamics are inextricably 
linked to eukaryotic gene expression. Among the many modifications that have been 
characterized, histone tail acetylation is most strongly correlated with transcriptional 
activation. In Metazoa, promoters of transcriptionally active genes are generally devoid 
of physically repressive nucleosomes, consistent with the contemporaneous binding of 
the large RNA polymerase II transcription machinery. The histone acetyltransferase 
p300 is also detected at active gene promoters, flanked by regions of histone 
hyperacetylation. Although the correlation between histone tail acetylation and gene 
activation is firmly established, the mechanisms by which acetylation facilitates this 
fundamental biological process remain poorly understood. To explore the role of 
acetylation in nucleosome dynamics, we utilized an immobilized template carrying a 
natural promoter reconstituted with various combinations of wild-type and mutant 
histones. We find that the histone H3 N-terminal tail is indispensable for activator, p300, 
                                                 
1  
Chapter two describes a study of the histone acetylation requirements for Nap1-
dependent nucleosome disassembly and transcription activation. I performed the 
following experiments shown in this chapter: Fig. 2.4C, 2.6A and B, and Fig. 2.7A-C. 
This work has been published in the journal, Proceedings of the National Academy of 
Sciences of the United States of America, and is presented here exactly as it appeared 
in Luebben, W.R., Sharma, N.S., Nyborg, J.K. 2010. Nucleosome eviction and 
activated transcription require p300 acetylation of histone H3 lysine 14. Proc Natl Acad 




and acetyl-CoA-dependent nucleosome eviction mediated by the histone chaperone 
Nap1. Significantly, we identify H3 lysine 14 as the essential p300 acetylation substrate 
required for dissociation of the histone octamer from the promoter DNA. Together, a 
total of 11 unique mutant octamer sets corroborated these observations and revealed a 
striking correlation between nucleosome eviction and strong activator and 
acetyl-CoA-dependent transcriptional activation. These novel findings uncover an 
exclusive role for H3 lysine 14 acetylation in facilitating the ATP-independent and 
transcription-independent disassembly of promoter nucleosomes by Nap1. Furthermore, 




Chromatin facilitates the extraordinary compaction of genomic DNA in all 
eukaryotes. Nucleosomes, the basic repeating unit of chromatin, are composed of two 
copies each of the core histone proteins H2A, H2B, H3, and H4 with 147 bp of DNA 
wrapped around the histone octamer (74, 75). Nucleosomes present an intrinsic 
paradox for the cell: They must form stable contacts with the DNA to compact the 
genetic material, and they must allow local disassembly to expose the underlying DNA 
for the chromosomal transactions required for life. Eukaryotes have evolved multiple 
strategies to negotiate the inherently repressive chromatin to access their genetic 
material, including posttranslational modifications of the nucleosomal histones (108). 
Histone modifications occur primarily on the N-terminal tails that extend beyond 
the nucleosome core particle. The first identified and most intensively studied histone 
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modification is acetylation (93, 109). Gene-associated histone H3 and H4 tail acetylation 
is one of the strongest predictors of transcriptional activity in eukaryotes (12, 109). In 
native chromatin, acetylation of specific lysine residues on the H3 and H4 N-terminal 
tails is nonrandom and highly ordered (110), a finding in agreement with the patterns of 
acetylation associated with multiple histone acetyltransferases (HATs) throughout 
eukaryotes (111-114). Histone tail acetylation has multiple effects on chromatin 
structure and fluidity. These include H4 acetylation-dependent relaxation of the 
chromatin fiber and recruitment of ATP-dependent chromatin-remodeling complexes via 
acetyl-lysine binding bromodomains (94, 115-119). However, the mechanism by which 
histone tail acetylation elicits chromatin reconfiguration and coupled transcriptional 
activation is unknown (12). 
In recent years, numerous high profile mapping studies of nucleosomes and their 
modifications identified nucleosome-free regions (NFRs) at the promoters of 
transcriptionally active genes (86, 120-125). The core promoter must be devoid of 
nucleosomes to enable binding of the RNA polymerase holoenzyme complex. Several 
studies have correlated the formation of promoter NFRs with the acetylation of specific 
lysines on the H3 tail (121, 123, 124, 126). Furthermore, the binding of the essential 
coactivator and HAT, p300, correlates with NFRs and adjacent regions of H3 
hyperacetylation (103, 121). These observations suggest an underlying functional 
connection between histone N-terminal tail acetylation and the disassembly of 
promoter-associated nucleosomes. However, the link between histone tail acetylation 
and NFR formation remains obscure. 
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Studies in our laboratory recently uncovered a biochemical pathway of activator 
and p300-dependent promoter nucleosome disassembly mediated by the histone 
chaperone Nap1 (107). Nucleosome eviction from our model retroviral promoter in vitro 
recapitulated activator-dependent nucleosome loss from this promoter in vivo (106). 
Nucleosome disassembly in vitro required purified activators, catalytically active p300, 
Nap1, and acetyl CoA (Ac-CoA). The four core histones served as the presumed p300 
acetylation substrates. Notably, promoter nucleosome disassembly was independent of 
ATP, chromatin-remodeling factors, and transcription per se, but required acceptor DNA 
and Nap1 (107). These observations highlight a unique function for Nap1 in acetylation-
dependent octamer disassembly and expand our understanding of the multiple 
mechanisms utilized by eukaryotes to mobilize repressive nucleosomes during gene 
activation. 
In the present study, we explore the role of histone acetylation by p300 during 
nucleosome disassembly and define the interconnectivities among histone acetylation, 
promoter nucleosome disassembly, and transcriptional activation. We utilized an in vitro 
immobilized template assay to investigate activator and Ac-CoA-dependent 
disassembly of nucleosomes from a native promoter. We compared chromatin 
templates composed of a mixture of wild-type histones and histones carrying lysine to 
arginine (K → R) N-terminal tail mutations. This analysis identified the histone H3 tail as 
the essential, functionally relevant acetylation target in nucleosome eviction by Nap1. 
Chromatin templates bearing these point mutations were also tested in parallel in vitro 
transcription assays. We observed a significant correlation between activator/Ac-CoA-
dependent nucleosome eviction and activator/Ac-CoA-dependent transcriptional 
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activation, establishing a critical functional link between H3 tail acetylation, NFR 
formation, and potent activation of transcription. We next introduced specific K → R 
point mutations in the H3 tail and tested chromatin bearing these mutations in both 
nucleosome eviction and transcriptional activation. Lysine 14 (H3 K14) emerged as the 
essential functional target of p300 acetylation. Remarkably, a single point mutation 
throughout the entire nucleosome, H3 K14 → R, was sufficient to block acetylation-
dependent nucleosome disassembly. Likewise, chromatin reconstituted with the 
reciprocal octamer (WT H3 K14, with K → R tail mutations throughout the remainder of 
the nucleosome), supported acetylation-dependent nucleosome eviction comparable to 
that of wild-type chromatin. These data identify H3 K14 acetylation as the pivotal event 
in Nap1-mediated promoter nucleosome disassembly. Together, these unique findings 
provide a molecular mechanism linking histone acetylation with gene activation and thus 




2.3a p300 TARGETS THE HISTONE AMINO-TERMINAL TAILS FOR 
NUCLEOSOME DISASSEMBLY 
To identify the specific histone targets of acetylation by p300, we used a 
chromatin-based immobilized template assay comprised of the model human T-cell 
leukemia virus (HTLV-1) promoter linked to a G-less cassette. This system has been 




Figure 2.1. Immobilized template/nucleosome disassembly 
assay. The schematic shows the 588-bp immobilized template 
carrying the natural T-cell leukemia virus (HTLV-1) model promoter 
linked to a downstream G-less cassette. The numbers denote 
specific steps in the reaction. The HTLV-1 promoter carries three 
viral cAMP response elements, or vCREs, which serve as binding 
sites for the Tax/pCREB complex. These elements are located at 
approximately -100, -200 and -250 bp upstream of the transcription 
start site. Chromatin is reconstituted on the 588-bp immobilized 
promoter template by the method of salt deposition, at a 
histone:DNA ratio that produces an average density of three 
nucleosomes/template (step 1). The nucleosomes assemble 
randomly on the template, as the native HTLV-1 promoter does not 
carry intrinsic nucleosome positioning sequences. Following 
chromatin assembly, highly purified Tax and pCREB are incubated 
with the template, followed by the addition of purified, full-length 
p300 and human Nap1 (step 2). The DNA-bound Tax/pCREB 
complex serves as a high-affinity binding site for p300, which is 
recruited via interaction between the activators and the KIX domain 
of p300. The addition of acetyl CoA and acceptor DNA initiates 
nucleosome disassembly (step 3). At the completion of the 
reaction, the immobilized promoter is magnetically isolated, the 
supernatant removed, and the template washed and resuspended 
in SDS sample dyes (step 4). Both the template-bound and 
supernatant fractions are analyzed by SDS-PAGE and the histones 
visualized by Coomassie staining. For the in vitro transcription 
assays, the same protocol is followed through step 2, except that 
nuclear extract (+/- Ac-CoA) is added in place of Nap1 and p300 
(which are supplied by the human T-cell nuclear extract). Following 
preinitiation complex formation, nucleoside triphosphates are 
added to initiate RNA synthesis and the transcripts are analyzed by 





carries three highly conserved 21-bp enhancer elements, called viral CREs (vCREs), 
located at -100, -200, and -250 bp upstream of the transcriptional start site (see 
ref. (127)). The vCREs serve as binding sites for the virally encoded transcriptional 
activator protein Tax, which binds together with the phosphorylated form of the cellular 
transcription factor cAMP response element binding protein, or CREB (pCREB). 
Together, the Tax/pCREB complex recruits p300 to promote strong HTLV-1 
transcriptional activation in vivo and in vitro (127). 
To begin characterization of acetylation-dependent nucleosome disassembly, we 
first performed a HAT assay to examine the pattern of p300 acetylation on both the 
template-bound histones and the histones liberated into the supernatant fraction 
(evicted). The 588-bp HTLV-1 promoter fragment was assembled into chromatin using 
highly purified, recombinant Xenopus histones by the method of salt deposition 
(Fig. 2.2B). Highly purified Tax, pCREB, p300, and human Nap1L1 (hNap1) (see Fig. 
2.2A) were preincubated with the chromatin template, and nucleosome eviction was 
assayed in the presence of [14C] Ac-CoA. Fig. 2.3A shows that all four core histones 
were released from the immobilized promoter template in the presence of [14C] Ac-CoA 
and that the evicted histones were highly acetylated. This observation is further 
corroborated in an eviction time course shown in Fig. 2.4A. 
Because the histone N-terminal tails are the primary targets of p300 (112), we 
next sought to determine if histone tail acetylation was required for nucleosome eviction. 
We prepared histone octamers carrying K → R point mutations at the known in vivo 
targets of acetylation on all four histones (110) (Fig. 2.3B). The K → R mutations retain 




Figure 2.2. (A) Purified activators, p300, Nap1 and histone octamers used in the assays presented herein. Highly 
purified Tax, pCREB, p300 and human Nap1 (hNap1) were separated on a 12% SDS polyacrylamide gel and 
visualized by Coomassie staining. (B) Octamers composed of the various combinations of wild-type and mutant 
core histones were analyzed on a 12% SDS-polyacrylamide gel to confirm the purity and consistency of each 
octamer preparation. The individual mixed octamer sets were assembled into chromatin in the immobilized HTLV-
1 promoter template and analyzed for their ability to support activator/Ac-CoA-dependent nucleosome 





Figure 2.3. Histone amino-terminal tail acetylation is required for nucleosome disassembly. (A) HAT assay 
reveals that H3 and H4 are highly acetylated in the evicted (supernatant) fraction. The nucleosome eviction assay 
was performed as shown schematically in Fig. 2.1. Briefly, the promoter template was assembled with wild-type core 
histones, and nucleosome eviction was analyzed following the addition of highly purified Tax, pCREB, p300, hNap1, 
and acceptor DNA; in the absence or presence of [14C] Ac-CoA. The purified proteins used in these assays are 
shown in Fig. 2.2A. The same gel was analyzed by Coomassie staining and PhosphorImage analysis. Molecular 
weight markers (M) are indicated. (B) Schematic of the four core histone N-terminal tails showing the positions of the 
lysine to arginine (K → R) point mutations (43). (C) Lysines in the N-terminal core histone tails are required for Ac-
CoA-dependent nucleosome eviction. Chromatin was assembled with either wild-type or K → R histone octamers. 
Nucleosome disassembly was assayed as described in A and Fig. 2.1 (using nonradiolabeled Ac-CoA). Dashed lines 





Figure 2.4. Histone acetyltransferase assays. (A) Time 
course HAT assay indicates that H3 and H4 are the 
primary p300 acetylation targets in the nucleosome eviction 
assay. Experiment performed as described in Fig. 2.3A and 
Fig. 2.1 using wild-type core histones and 14C-labeled 
acetyl-CoA in place of unlabeled acetyl CoA. The template-
bound and evicted histones were separated by 12% SDS-
PAGE and visualized by Coomassie staining. The gel was 
dried and histone acetylation was visualized by 
PhosphorImager analysis. Minutes following [14C] Ac-CoA 
addition are indicated. (B) To accompany the nucleosome 
disassebmly experiment shown in Fig. 2.5A, a HAT assay 
was performed to analyze the p300 histone acetylation 
patterns specific to each “mixed octamer” set, carrying 
various K→R point mutations. The nucleosome 
disassembly assay was performed as decribed for the 
experiment shown in Fig. 2.5A, except [14C] Ac-CoA was 
used in place of unlabeled Ac-CoA. (C) To accompany the 
nucleosome eviction assay shown in Fig. 2.6B, we 
performed a HAT assay to confirm p300 acetylation activity 
on chromatin assembled with the H3 K→R tail mutants. 
The HAT assay was performed on the entire reactions at 5 




Octamers composed of either wild-type histones, or histones carrying the K → R point 
mutations, were assembled in parallel into chromatin on our model promoter template, 
incubated with purified Tax, pCREB, p300, and Nap1, and assayed for nucleosome 
eviction in the absence or presence of Ac-CoA. Fig. 2.3C shows that chromatin carrying 
the K → R tail mutations does not support Ac-CoA-dependent nucleosome disassembly 
(lanes 3 and 4), indicating that the histone N-terminal tails serve as the functionally 
relevant p300 acetylation targets. From the data presented in Fig. 2.3., we conclude that 
p300 acetylation of lysine residues present in one or more of the four core histone tails 
is required for Nap1-mediated disassembly of promoter-associated nucleosome 
 
2.3b H3 N-TERMINAL TAIL LYSINES ARE REQUIRED FOR NUCLEOSOME 
EVICTION AND TRANSCRIPTIONAL ACTIVATION 
To identify the specific core histone tail (or tails) that functionally support 
nucleosome disassembly, we prepared four unique sets of histone octamers (mixed 
octamers) using combinations of wild-type histones and histones carrying the N-terminal 
K → R mutations (Fig. 2.2B). Each of the mixed octamer sets were assembled into 
chromatin on the immobilized HTLV-1 promoter and assayed for acetylation-dependent 
nucleosome disassembly using purified components, exactly as described above. 
Remarkably, these experiments revealed that the lysines present on the N-terminal tails 
of H2A, H2B, and H4 were dispensable and that wild-type histone H3 alone was 
sufficient for acetylation-dependent nucleosome disassembly (Fig. 2.5A). An eviction 




Figure 2.5. The H3 amino-terminal tail is required for nucleosome disassembly and transcriptional activation. 
(A) Mixed octamers were prepared using combinations of wild-type histones and histones carrying K → R tail 
mutations (see Fig. 2.3B). The mixed octamers were assembled into chromatin and tested for their ability to support 
activator/Ac-CoA-dependent nucleosome disassembly, exactly as described in the Fig.2.3 A legend (and Fig. 2.1). (B) 
Direct comparison of chromatin templates carrying the wild-type H3 tail assembled together with K → R tail mutations 
in H2A, H2B, and H4, with the reciprocal combination of core histones. (C and D) Using the chromatin templates 
shown in A and B, in vitro transcription reactions were performed using T-cell nuclear extract in the absence or 
presence of activators (Tax/pCREB) and/or Ac-CoA. The transcript (RNA) and recovery standard (RS) are indicated. 
The chromatin samples in 2C (lanes 1–9) and 2D are slightly underassembled, enabling visualization of “basal” 




 confirm that the H3 N-terminal tail served as the functionally relevant p300 acetylation 
target, we compared nucleosome eviction on chromatin composed of K → R H3, 
assembled with wild-type H2A, H2B, H4, in parallel with the reciprocal chromatin, wild-
type H3, assembled with K → R H2A, H2B, H4. Fig. 2.5B establishes that acetylation-
dependent nucleosome eviction exclusively requires lysine residues present on the H3 
N-terminal tail. 
The disassembly of nucleosome octamers from our model promoter fragment 
must, by definition, reduce nucleosome density on the template. Because the fragment 
is 588 bp in length and assembles ∼3 nucleosomes (107), it is likely that the core 
promoter is nucleosome-free on a significant fraction of the templates. We therefore 
hypothesized that chromatin templates permissive to nucleosome eviction should serve 
as excellent substrates for preinitiation complex formation and activated transcription.
 Similarly, templates reconstituted with chromatin carrying K → R point mutations 
that block nucleosome eviction should also block activated transcription. As such, the 
chromatin templates used in Fig. 2.5A and B provided us with powerful tools to directly 
test whether acetylation-dependent nucleosome disassembly is a prerequisite for 
transcriptional activation. Of note, we previously established that transcription from our 
chromatin-assembled model HTLV-1 promoter is strongly dependent upon Tax/CREB, 
p300, and Ac-CoA (72, 104, 107). To test transcriptional activation from the same wild-
type and K → R mutant chromatin templates described in Fig. 2.5 A and B above, we 
performed in vitro transcription assays in the absence or presence of activators 
(Tax/pCREB) and/or Ac-CoA. The experiments were carried out similar to the protocol 
shown in Fig. 2.1, except that following Tax/pCREB binding, nuclear extract was 
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incubated with the templates to enable preinitiation complex formation. The T-cell 
nuclear extract supplies the RNA polymerase holoenzyme complex, p300, and 
nucleosome disassembly activity indistinguishable from Nap1 (107). Remarkably, we 
observe a precise correlation between activator/Ac-CoA-dependent nucleosome 
eviction and strong activator/Ac-CoA-dependent transcriptional activation (Fig. 2.5). 
Specifically, the three octamers carrying wild-type H3 supported both eviction and 
transcription, whereas the three octamers carrying K → R mutations in the H3 tail failed 
to support eviction and transcription (Fig. 2.5 C and D; summarized in Table 2.1). 
Together, the findings presented in Fig. 2.5 and Table 2.1 demonstrate that the histone 
H3 tail alone is sufficient for acetylation-dependent nucleosome disassembly and 
transcriptional activation and implicate one (or more) of the H3 tail lysine residues as 
the functionally relevant p300 acetylation target (e.g., K9, K14, K18, and/or K23). 
Further, the precise correspondence between nucleosome eviction and transcriptional 
activation directly links these two fundamental biological processes (Table 2.1). 
 
2.3c LYSINE 14 ON THE H3 N-TERMINAL TAIL IS NECESSARY AND SUFFICIENT 
FOR NUCLEOSOME EVICTION AND TRANSCRIPTIONAL ACTIVATION 
Based on the data presented above, we next focused on identifying the specific 
H3 N-terminal tail lysine(s) responsible for supporting acetylation-dependent 
nucleosome eviction. We first prepared two H3 tail mutants carrying wild-type K9 (WT 
K9) or wild-type K14 (WT K14), each against a background of K → R mutations at the 
other three positions in the H3 tail (Fig. 2.6A). Octamers composed of H3 tail mutants, 




Figure 2.6. Point mutations in the H3 tail implicate K14, and not K9, as the functional target of 
acetylation in activator-dependent nucleosome disassembly and transcriptional activation. (A) 
Schematic of the H3 tail showing the K → R point mutations. (B and C) The histone H3 tail mutants were 
reconstituted with wild-type core histones H2A, H2B, and H4. The chromatin templates were assayed for 




 into chromatin and tested for their ability to support activator-dependent and Ac-CoA-
dependent nucleosome disassembly and transcriptional activation, as described 
in Fig. 2.5. As shown in Fig. 2.6 B and C, nucleosomes carrying wild-type H3 K9, with 
K → R mutations at positions 14, 18, and 23, failed to support nucleosome eviction or 
transcriptional activation. In marked contrast, nucleosomes carrying wild-type H3 K14, 
with K → R mutations at 9, 18, and 23, supported both eviction and transcription, 
comparable to that observed with wild-type chromatin. We verified K14 acetylation with 
this mutant by mass spectrometry. As a control, a HAT assay time course demonstrates 
that chromatin assembled with both of these mutants support p300 acetylation 
throughout the nucleosome (Fig. 2.4C). These results establish that acetylation of H3 
K14 is sufficient for both Nap1-mediated nucleosome disassembly and activator-
dependent in vitro transcription.  
To further establish the functional relevance of K14 acetylation, we introduced a 
single K → R point mutation at this position in the H3 tail and reconstituted chromatin 
templates with WT H2A, H2B, and H4 (Fig. 2.7A). Fig. 2.7B shows that this single 
K14 → R point mutation within the nucleosome blocks acetylation-dependent 
nucleosome eviction. We next prepared chromatin carrying K → R point mutations at 
every major N-terminal tail lysine residue in the nucleosome, except position H3 
K14. Fig. 2.7C shows that wild-type H3 K14, present as the only major acetylation site, 
supports disassembly of the nucleosome octamer from the promoter DNA. These 
experiments establish that H3 K14 is both necessary and sufficient for activator, p300, 




Figure 2.7. H3 K14 is necessary and sufficient for acetylation-dependent nucleosome disassembly. (A) 
Schematic of the H3 tail showing the K → R point mutations. Relevant wild-type lysines are shown in red. (B) Each 
of the indicated H3 tail mutant was reconstituted with wild-type H2A, H2B, and H4 and tested in 
activator/Ac-CoA-dependent nucleosome eviction assays. (C) The “WT K14” histone H3 tail mutant (K9, 18, 
23 → R) was reconstituted with core histones carrying K → R mutations throughout the H2A, H2B, and H4 N-
terminal tails (see Fig. 2.2B). Importantly, this chromatin (lanes 5 and 6) carries H3 K14 as the only major site of 
acetylation throughout the nucleosome. This chromatin was tested in parallel with H3 WT K14 reconstituted with 






We provide compelling evidence that p300 acetylation of histone H3 lysine 14 is 
essential for activator-dependent promoter nucleosome disassembly by the histone 
chaperone Nap1. Histone H3 K14 is also required for robust activator and acetyl-CoA-
dependent transcription in vitro. Remarkably, introduction of only a single arginine point 
mutation at position H3 K14 was sufficient to block promoter nucleosome disassembly, 
demonstrating that acetylation at any other lysine throughout the nucleosome cannot 
support eviction. In the reciprocal experiment, chromatin carrying wild-type H3 K14, with 
K → R tail mutations at every major acetylation target throughout the nucleosome, fully 
supported acetylation-dependent nucleosome eviction. These data convincingly 
demonstrate that H3 K14 is a highly specific, nonredundant acetylation substrate that 
serves an essential role in nucleosome disassembly. As summarized in Table 2.1, a 
total of 13 unique octamer sets were reconstituted into chromatin on our model 
promoter template and tested for their ability to support activator (Tax/pCREB) and Ac-
CoA-dependent nucleosome disassembly by Nap1. Eight of these chromatin templates 
were tested in parallel in activator and Ac-CoA-dependent in vitro transcription assays. 
Together, these studies revealed a compelling correlation between acetylation-
dependent nucleosome eviction and activator-dependent transcriptional activation and 
establish H3 K14 as the single functionally relevant p300 target required for Nap1-
mediated nucleosome eviction. These previously undescribed findings provide evidence 
demonstrating a direct role for the histone chaperone Nap1 in the disassembly of the 
nucleosome octamer following a highly specific acetylation event  
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Table 2.1. Summary of the histone tail mutants, and their effect on 
acetylation-dependent nucleosome disassembly and transcriptional 
activation  
Octamer Eviction? Transcription? 
(wt) H2A, H2B, H3, and H4 Yes Yes 
KR H2A, H2B, H3, and H4 No n.d. 
KQ H2A, H2B, H3, and H4 No n.d. 
Mixed Histone Octamers   
(KR) H3, H4 / (wt) H2A, H2B No No 
(KR) H2A, H2B / (wt) H3, H4 Yes Yes 
(KR) H2A, H2B, H3 / (wt) H4  No No 
(KR) H2A, H2B, H4 / (wt) H3  Yes Yes 
(KR) H3 / (wt) H2A, H2B, H4 No No 
Histone H3 Tail Mutations   
wt K9; K14,18,23R  
(wt) H2A, H2B, and H4  
No No 
wt K14; K9, 18, 23R 
(wt) H2A, H2B, and H4 
Yes Yes 
wt K14; K9,18,23R 
(KR) H2A, H2B, and H4 tails 
Yes n.d. 
K14R; wt K9, 18, 23 
(wt) H2A, H2B, and H4 
No n.d. 
wt K23; K9, 14, 18R  
(wt) H2A, H2B, and H4 
No n.d. 
n.d. Not determined. 
All eviction results are activator (Tax/pCREB), p300, Nap1, acceptor DNA, and Ac-CoA 
dependent. Eviction reactions were scored based on the detection of histone proteins in 
the supernatant fraction, as described in the Methods section. The in vitro transcription 
reactions were scored based on the strong activation observed in the presence of 
Tax/pCREB and Ac-CoA. These data summarize the results presented herein, and 




(for review, see ref. (128)). Further, these studies demonstrate a direct functional 
linkage between site-specific histone acetylation, promoter nucleosome disassembly by 
Nap1, and gene activation. A model incorporating these sequential steps in the 
conversion of a silent gene to a transcriptionally active gene is shown in Fig. 2.8. 
Identifying an exclusive role for the H3 tail in acetylation-dependent nucleosome 
eviction was unexpected, as both the H3 and H4 tails are well-established acetylation 
targets in nucleosome dynamics and gene activation (12, 109, 128). The H4 tail has 
been shown to mediate internucleosomal interactions and stabilize higher-order 
chromatin structures (94, 96, 129, 130). Specifically, acetylation of H4 K16 facilitates 
relaxation of the chromatin fiber, creating a template more permissive to gene activation 
(94, 116, 129). The natural promoter fragment used in our assays accommodates up to 
three randomly positioned nucleosomes, and immobilization of this fragment on the 
streptavidin-coated magnetic bead enforces a physical distance between the templates. 
As such, the chromatin used in our model system is unlikely to undergo extensive intra- 
and/or interfiber interactions, and the requirement for H4 tail acetylation is therefore 
bypassed. Taken together, our findings reveal the functional uncoupling of these two 
critical, yet mechanistically distinct, histone acetylation pathways. Importantly, the 
segregation of these two pathways enabled identification of H3 K14 as the precise 
acetylation target required for disassembly of the histone octamer from the DNA. 
Based on chromatin modification studies that span decades, two distinct, yet 
mutually compatible models have emerged to consider the outcome of histone 
acetylation on chromatin dynamics (for review, see ref. (128)). In the first model, histone 
tail acetylation induces changes in the physical properties of the nucleosome that 
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Figure 2.8. Model showing the sequential events in acetylation-dependent nucleosome disassembly. 
p300 is recruited to the promoter via interaction with activators, whereupon it acetylates the histone tails of 
the promoter-associated nucleosomes. Following H3 K14 acetylation, Nap1, via interaction with p300 
(37, 38) mediates disassembly of the nucleosome octamer from the promoter DNA, producing a 





reduce inter- or intranucleosomal contacts, producing a more relaxed chromatin fiber. In 
the second model, acetylated lysines serve as recognition elements to mediate 
recruitment of chromatin modifying proteins via bromodomains. Our studies described 
herein are inconsistent with the first model, as the acetylation of a single lysine—at a 
very specific position within the nucleosome—largely negates a role for charge 
neutralization and/or reduced nucleosome stability. The specific identification of H3 K14, 
however, resonates with numerous previous studies that may provide clues to the 
mechanism of disassembly. Analysis of the acetylation patterns of native histones 
revealed that H3 K14 acetylation is very specific and ordered and is one of the lysine 
positions found to be highly acetylated in vivo (110). Consistent with these observations 
are the ubiquitous findings that H3 lysine 14 is the primary or major acetylation target of 
multiple HATs. These HATs are expressed throughout eukaryotes and include purified 
Gcn5, the Spt-Ada-Gcn5 acetyltransferase (SAGA), Ada2, and NuA3 complexes, 
CBP/p300-associated factor (PCAF), CREB binding protein (CBP), and p300 (111-114). 
The highly specific targeting of H3 K14 by multiple HATs provides strong evidence for a 
significant biological outcome associated with acetylation at this position. Of note, the 
ATP-dependent, bromodomain-containing, yeast chromatin-remodeling complex RSC 
(chromatin structure remodeling complex) has been shown to specifically bind H3 
K14Ac, but not H3 K9Ac (or H3 K14 → Q) (117). In our system, however, the p300 
bromodomain does not participate in recruitment of the coactivator to the promoter, 
because the chromatin template is assembled with unacetylated histones, and p300 is 
brought to the promoter via KIX domain interaction with DNA-bound Tax/pCREB (48, 
127). Furthermore, we show herein that nucleosomes carrying K → R mutations 
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throughout the four core histone tails—except H3 K14—support eviction (see Fig. 2.7C). 
Therefore, additional acetyl-lysine interactions are unavailable to the p300 
bromodomain during K14 acetylation. We cannot exclude, however, a role for a 
bromodomain/K14Ac interaction during disassembly of the octamer by Nap1. In support 
of this model, previous studies have shown an interaction between Nap1 and CBP/p300 
in vivo and in vitro (131, 132). Determining the detailed mechanism by which the 
Nap1/p300 complex facilitates eviction of the H3 K14 acetylated nucleosomes is of 
significant interest. 
In summary, the downstream effects of histone N-terminal tail acetylation have 
been known for decades, yet defining the precise mechanism(s) by which histone 
acetylation promotes gene expression has been elusive. We demonstrate here that 
p300 acetylation of H3 K14 is both necessary and sufficient for Nap1-mediated 
disassembly of the histone octamer from the promoter DNA, and concomitant activator 
and Ac-CoA-dependent transcription in vitro. These unique findings link a specific 
histone tail acetylation event, NFR formation, and transcriptional activation in vitro. As 
such, they provide a molecular framework to interpret specific histone acetylation events 
in the context of NFRs and gene activation in vivo. Although our studies establish a 
direct connection between p300 acetylation of H3 K14 and histone chaperone mediated 
nucleosome disassembly, it is likely that this mechanism works in concert with 
additional posttranslational histone modifications and chromatin effector proteins to fine-





2.5 MATERIAL AND METHODS 
 
2.5a PROTEIN EXPRESSION AND PURIFICATION 
pCREB (untagged) (133), Tax-His6 (134), human Nap1 (GST-hNap1L1) (135), and 
His6-p300 were purified using the methods described in their accompanying references 
(see also ref. (107)). Xenopus histones carrying the indicated H3 point mutations were 
prepared by site-directed mutagenesis and confirmed by sequence analysis. Histone 
proteins were expressed and purified as previously described (136). All the purified 
proteins are shown in Fig 2.2A and B. The GST-hNap1 expression plasmid was a gift 
from M. Giacca (International Centre for Genetic Engineering and Biotechnology, 
Trieste, Italy) and G. Steger (Institute of Virology, University of Cologne, Cologne 
Germany) (135), and the plasmids encoding the four core histone K → R point mutants 
(shown in Fig. 2.2B) were a gift from R. Roeder (Rockefeller University, New York, NY) 
(137). 
 
2.5b CHROMATIN ASSEMBLY, NUCLEOSOME DISASSEMBLY, IN VITRO 
TRANSCRIPTION ASSAYS 
A 588-bp fragment carrying the complete HTLV-1 promoter linked to a 290-bp G-less 
cassette was prepared by PCR, incorporating a biotin group at the upstream end of the 
fragment and immobilized on streptavidin-coated magnetic Dynabeads (see 
refs.(107) and (48)). The PCR fragment was assembled into chromatin by salt 
deposition, as previously described (107). Nucleosome disassembly (see 
schematic, Fig. 2.1) and in vitro transcription assays were performed as described 
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previously (48, 107). Although not indicated in each figure, all nucleosome eviction 
































CHAPTER THREE  
TROUBLESHOOTING NAP1-DEPENDENT NUCLEOSOME DISASSEMBLY AND 




3.1 RESULTS AND DISCUSSION 
 
3.1a NAP1-DEPENDENT NUCLEOSOME DISASSEMBLY TROUBLESHOOTING 
EFFORTS 
 The Nap1-dependent nucleosome disassembly assay is complicated due to the 
many components of the reaction including the chromatin substrate, recombinant 
proteins pCREB, Tax, p300 and Nap1, reaction buffer, Ac-CoA, and competitor DNA. 
Table 3.1 summarizes the troubleshooting efforts put forth by myself and my colleagues 
from April 2010-January 2013 to troubleshoot the Nap1-dependent nucleosome 
disassembly assay. 
 The biotinylated promoter fragment used in the nucleosome disassembly assay 
is made using PCR. The PCR reaction was traditionally purified using phenol/chloroform 
extraction followed by ethanol precipitation to rid of NTPs and polymerase. We 
hypothesized that the purification method being used to purify the 588 bp DNA was 
inhibiting Nap1-dependent nucleosome disassembly. This hypothesis was tested by 
purifying the biotinylated 588 bp DNA using (1) phenol/chloroform extraction, (2) FPLC 
purification or (3) a centrifugal filter device and testing each in a nucleosome  
                                                 
2 Chapter three summarizes the work performed between April 2010 and January 2013 
in an effort to regain the use of the Nap1-dependent nucleosome disassembly assay 
and Ac-CoA-dependent in vitro transcription system. The work summarized in Tables 
3.1 and 3.2 was performed by myself and multiple others in the laboratory. I performed 





Table 3.1. Summary of troubleshooting efforts in obtaining Nap1-dependent 
nucleosome disassembly from the HTLV-1 promoter. Experiments were 
performed as described in (1), with the above variations. 
COMPONENT  VARIATIONS UTILIZED 
Immobilized 
DNA  
Optimization of PCR, FPLC purification vs phenol/chloroform 
and EtOH precipication  
Reaction 
buffer  
Excluding EDTA and including zinc, titration of MgCl2 and KCl, 
bought all new reagents  
Chromatin 
Assembly  
Modifying salt deposition method to include BSA and/or Nap1 
during assembly, ACF/Nap1 method of assembly, titration of 
histone:DNA  
Ac-CoA  Three different lots, [14C] Ac-CoA, titration  
Acceptor DNA  146 bp DNA (Widom sequence), polydA:dT, pUC19, 588 bp 
DNA, titration of the above  
pCREB  Four different protein preparations, titration of all the 
preparations  
Tax  Three different protein preparations, titration of all the 
preparations  
p300  Three different protein preparations, titration of all the 
preparations  
Nap1 Five different preparations of GST-tagged hNap1, five different 




Two different nuclear extract preparations, inclusion of 
phosphatase inhibitor during nuclear extract incubation, 
performed incubation period at 4°C and 30°C, titration of 




disassembly assay. We found that the method of DNA preparation did not influence the 
outcome of the experiment, as visualization of histones in the supernatant was 
unsuccessful (data not shown).  
The buffer conditions used in previous nucleosome disassembly experiments 
were 50 mM Tris pH 7.9, 100 mM KCl, 6.25 mM MgCl2, 1 mM EDTA, 20% glycerol (v/v) 
and 2 mM DTT. p300 is a zinc containing protein and requires zinc to be  
properly folded. We hypothesized that the EDTA in the reaction buffer was chelating 
zinc, resulting in misfolded p300, preventing proper formation of the quaternary complex 
and preventing disassembly of nucleosomes by Nap1. Therefore, a modified reaction 
buffer was prepared, containing 10 μM Zinc and no EDTA, and then subsequently used 
in a Nap1-dependent nucleosome disassembly assay. Again, we were unable to 
visualize histones in the supernatant (data not shown). Divalent cations (particularly 
Mg2+) have been shown to promote folding of chromatin fibers. We hypothesized that if 
the MgCl2 or KCl concentrations in the reaction butter were not optimal, it could affect 
the folding state of the chromatin (i.e. beads on a string or folded/oligomerized) and 
therefore affect the efficiency of the Nap1-dependent nucleosome disassembly assay. 
To test this hypothesis, reaction buffer was made, ranging from 0-8 mM MgCl2 and 50-
100 mM KCl and subsequently tested in a Nap1-dependent nucleosome disassembly 
assay. Again, we failed to visualize histones in the supernatant (data not shown). Lastly, 
to avoid the possibility of contamination, new reagents were bought and new solutions 
made and then tested in a Nap1-dependent nucleosome disassembly assay. Again, we 
did not observe histones in the supernatant (data not shown). 
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 Both the salt deposition method of chromatin assembly and the ACF/Nap1 
method of chromatin assembly were used in past studies to produce chromatin 
templates permissive to Nap1-dependent nucleosome disassembly (1, 107). However, 
more recently, chromatin assembled by both of these methods failed to disassemble 
nucleosomes from the promoter template in a Nap1-dependent nucleosome 
disassembly assay (data not shown).  
Past experiments permissive to both nucleosome disassembly and transcription 
activation typically utilized a 4:7 or 5:7 histone:DNA (mass:mass) ratio. However, due to 
variability in DNA and protein quantitation it can be difficult to compare histone:DNA 
ratios anytime a new preparation of DNA or histone octamer is used. Therefore, the 
appropriate histone:DNA that should be used, at least in part for in vitro transcription 
assays, is empirically determined by titrating the histone:DNA ratios. As such, 
histone:DNA ratios were titrated from 3:7 – 14:7 to account for these variabilities. 
However, none of the histone:DNA ratios tested supported Nap1-dependent 
nucleosome disassembly (data not shown). 
One possibility for the Nap1-dependent nucleosome disassembly assay not 
working was that protein preparations had “gone bad” and become inactive. To test this 
hypothesis, members of the Nyborg Laboratory, as well the Protein Expression and 
Purification Facility, purified several preparations of each recombinant protein, 
summarized in Table 3.1. Again, however, histones were not evicted from the promoter 
template when testing and titrating each protein preparation in Nap1-dependent 
nucleosome disassembly (data not shown) 
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In the past, A CEM (HTLV-1 negative T-cell line) nuclear extract had been 
frequently used as the source of p300 and Nap1 in the nucleosome disassembly assay. 
We hypothesized that if p300 or Nap1 recombinant protein preparations were no longer 
active or functional, then nuclear extract would supplement the required components. 
As such, several different nuclear extract preparations were tested in the nucleosome 
disassembly assay, including one that had supported nucleosome disassembly in past 
experiments. These experiments were unsuccessful.  We then hypothesized that a 
phosphatase in the nuclear extract was dephosphorylating pCREB, preventing the 
recruitment of p300 and therefore preventing Nap1-dependent nucleosome disassembly 
from the promoter template. To test this hypothesis, phosphatase inhibitors were added 
when using the nuclear extract in a nucleosome disassembly assay. Additionally, 
incubation of the pCREB/Tax bound promoter template with nuclear extract was 
performed at 4°C rather than 30°C to prevent possible dephosporylation. Unfortunately, 
these modifications did not produce a positive result. 
Nap1-dependent nucleosome disassembly from the HTLV-1 promoter is 
acetylation-dependent. Therefore, the quality of the Ac-CoA used in the reaction is 
extremely vital to the success of the experiment. As such, fresh preparations of Ac-CoA 
were prepared and tested in Nap1-dependent nucleosome disassembly. Again, 
histones were undetectable in the supernatant (data not shown).  
Lastly, there is a requirement for acceptor DNA for Nap1-dependent nucleosome 
disassembly. Numerous types of DNA function as acceptor DNA, as long as the DNA is 
more than 146 bp in length, suggestive of a nucleosome forming on the acceptor DNA 
upon nucleosome disassembly from the promoter template (unpublished data, Neelam 
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Sharma). Therefore, a variety of DNAs were titrated and tested during Nap1-dependent 
nucleosome disassembly, including 146 bp (“601” Widom sequence) DNA, pUC19 
plasmid DNA, the alternating copolymer poly(dA:dT) and a non-biotinylated 588 bp 
promoter template. Similar to the experiments already mentioned, the appearance of 
evicted histones in the supernatant was not detected (data not shown). 
Unfortunately, we have been unsuccessful in determining why we no longer 
visualize nucleosome disassembly from the HTLV-1 promoter template. It is likely that 
the failure to observe nucleosome disassembly is a combination of technical problems 
and/or reagents that have yet to be resolved. However, because we observed a strong 
correlation between a chromatin template being permissive to nucleosome disassembly 
also being permissive to Ac-CoA dependent transcription activation, we simultaneously 
focused research efforts on optimization of Ac-CoA dependent in vitro transcription 
assays.  
 
3.1b Ac-CoA DEPENDENT IN VITRO TRANSCRIPTION TROUBLESHOOTING 
EFFORTS 
Concomitant with Nap1-dependent nucleosome disassembly assays not working, 
in vitro transcription assays were no longer Ac-CoA dependent. As such, similar 
approaches used to troubleshoot Nap1-dependent nucleosome disassembly were taken 
to optimize Ac-CoA-dependent in vitro transcription conditions and are summarized in 
Table 3.2.  
A key component of the in vitro transcription assay is the HTLV-1 chromatin 




COMPONENT  VARIATIONS UTILIZED 
DNA template  Immobilized 588 bp DNA, 4xTRE plasmid, -306 HTLV-1 
plasmid, titration of the above  
Histones  Titration of xenopus and human histones  
Chromatin 
Assembly  
Adding Nap1 during salt deposition method, adding Nap1 after 
salt deposition method, ACF/dNap1 assembly method  
Ac-CoA  Three different lots  
pCREB  Four different protein preparations, titration  
Tax  Four different protein preparations of His-tagged Tax, one 
protein preparation of strep-tagged Tax, titration  
p300  Exogenous p300 addition, three different preps of His-
tagged p300, one preparation of strep-tagged p300  
Nuclear extract  Two different nuclear extract preparations, addition of 
phosphatase inhibitors, incubation at 4°C vs 30°C, addition of 
ATP, titration  
 
Table 3.2. Summary of troubleshooting efforts in obtaining Ac-CoA 
dependent transcription activation from the HTLV-1 promoter. 
Experiments were performed as described in (1), with the above described 
variations. Underlined and bolded indicates the variation was successful in 
identifying conditions that supported Ac-CoA dependent transcription. 
54 
 
studying Tax-mediated, Ac-CoA-dependent in vitro transcription (48, 72, 104, 107, 138, 
139). In addition, assembly by an ATP-dependent method as well as by a salt 
deposition method had supported Ac-CoA-dependent in vitro transcription (48, 72, 104, 
107, 138, 139). Perhaps most importantly, in reference to the chromatin substrate, as 
the histone:DNA ratio is increased, basal transcription (in the absence of activator 
proteins) decreases, eventually becoming completely transcriptionally repressed. 
Compared to naked DNA, maximally activated transcription from a chromatin template 
is highly reliant on Ac-CoA (1, 104). 
 As mentioned, comparable efforts were used while troubleshooting Nap1-
dependent nucleosome disassembly and Ac-CoA-dependent transcription, largely due 
in part because of the initial similar experimental set up, where in both experiments the 
chromatin substrate is preincubated with pCREB and Tax and then subsequently 
incubated with p300 and Nap1 (or nuclear extract in the case of in vitro transcription) 
and Ac-CoA. After many attempts and failed experiments using an immobilized 
fragment promoter template assembled into chromatin by the salt deposition method, 
we turned to the experimental conditions used in Georges et al and Konesky et al (104, 
139). 
 Georges et al used a plasmid template (p4XTRE) assembled into chromatin by 
the ACF/Nap1 method. Therefore, we purified ACF from SF9 cells and assembled 
chromatin on the p4XTRE plasmid using the ACF/Nap1 method as described in (140), 
employing this chromatin substrate in in vitro transcription assays. Concurrently with this 
method, we began adding “exogenous” recombinant p300 to the assay to supplement 
the “endogenous” p300 supplied by the nuclear extract. Using these techniques, we 
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successfully observed Ac-CoA dependent transcription activation from the chromatin 
templates tested. 
 Interestingly, we found varying dependency on the addition of exogenous p300 
for Ac-CoA-dependent transcription activation when comparing a plasmid chromatin 
template to a fragment chromatin template. Briefly, Ac-CoA dependent transcription 
activation is completely dependent upon exogenous p300 addition using a fragment 
chromatin template, whereas exogenous p300 addition enhances already Ac-CoA-
dependent transcription activation from a plasmid chromatin template. These findings 
are discussed in more detail in Chapter 4. 
 Activation of transcription from in vitro assembled chromatin templates is 
extremely sensitive to the level at which the chromatin templates are assembled with 
nucleosomes. Therefore, perhaps the most important requisite for successful 
experimentation is an appropriate histone:DNA ratio at which basal transcription is 
repressed but able to become activated upon the experimental condition being tested. 
This is only achieved through meticulous titration of histone:DNA ratios, as variation is 
found in the quanitation of DNA and histone octamer and from researcher to researcher. 
An example of titrating the histone:DNA to find the “window” of Ac-CoA dependency is 
shown in Figure 3.1. Histone:DNA was titrated on two different chromatin templates, a 
plasmid chromatin template (Figure 3.1A), and a fragment chromatin template (Figure 
3.1B). On both chromatin templates, as the histone:DNA ratio is increased (i.e. number 
of nucleosomes per template is increased), Ac-CoA independent transcription 
decreases as the Ac-CoA dependency for transcription activation increases (Figure 




Figure 3.1. Dissection of Ac-CoA independent activation and Ac-CoA dependent activation with increasing 
histone:DNA (µg:µg).  A) Plasmid chromatin template was assembled into chromatin using the ACF/Nap1 method at 
increasing histone:DNA as indicated. B)Fragment chromatin template was assembled into chromatin using the salt 
deposition method at increasing histone:DNA as indicated. Chromatin templates were incubated with the indicated 
recombinant proteins and Ac-CoA and tested in in vitro transcription using a CEM nuclear extract. Relative Ac-CoA 
independent transcription activation was determined by setting the lowest histone:DNA ratio  in the absence of Ac-
CoA but in the presence of activator or activator/coactivator  to 100. Ac-CoA dependent fold activation was 
determined for each histond:DNA ratio by dividing the amount of transcript in the presence of activator and Ac-CoA by 




we have verified and recapitulated previous findings from the laboratory and from 
literature. These experiments are discussed below. 
 
 3.1c  RECAPITULATION AND VERIFICATION OF PREVIOUS FINDINGS USING 
Ac-CoA DEPENDENT IN VITRO TRANSCRIPTION ACTIVATION CONDITIONS 
 Using the conditions found to support Ac-CoA dependent transcription activation 
(i.e addition of exogenous p300), we have confirmed previous reports of a 
transactivation mutant of Tax that fails to activate transcription from the HTLV-1 LTR, as 
well as verify a previously proposed transcriptionally defective chromatin template.  
 In 1990, mutational analysis of Tax by Smith and Green (141) produced 52 
mutants of Tax that were subsequently used to study the transactivating properties of 
Tax. Of these Tax mutants, mutant number 47 (Tax M47,L319R, L320S) had severely 
impaired transactivation properties in vivo at the HTLV-1 LTR. As such, Tax M47 has 
been extensively studied and characterized by our laboratory, as well as others. In vivo 
and in vitro studies from our laboratory indicate that Tax M47 has decreased 
transcriptional activation from the HTLV-1 LTR [(106) and Sharma unpublished]. In 
agreement with this, we have recently shown that Tax M47 is defective for transcription 
activation from in vitro assembled chromatin templates in the presence and absence of 
exogenous p300 addition (Figure 3.2, lane 4 vs 8 and lane 6 vs 10).  
 In the studies presented in Chapter 2, we observed a strong correlation between 
a chromatin template being permissive to Nap1-dependent nucleosome disassembly 
also being permissive to Ac-CoA dependent transcription activation. From this 
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Figure 3.2. An in vitro transcription assay comparing the transactivating activity of wild-type Tax to a Tax mutant 
(Tax M47).  Transcription reaction mixtures contained CEM nuclear extract and purified recombinant pCREB, 
Tax, Tax M47, p300 and Ac-CoA as indicated. The recovery standard, RNA transcript and size markers are 
indicated. Relative transcription was calculated by dividing the transcript with the recovery standard, with pC/Tax 





correlation, we predicted that a single mutation, histone H3 lysine 14 to arginine that 
was defective for Nap1-dependent nucleosome disassembly would also be defective for 
Ac-CoA dependent transcription activation. Using newly optimized Ac-CoA dependent 
transcription activation conditions, we tested an immobilized chromatin template 
carrying the H3K14R mutation in an in vitro transcription assay. Figure 3.3A shows that 
a single mutation at H3K14R results in a decrease in transcription activation from the 
HTLV-1 promoter template, compared to wild-type (lane 6 vs 12). A graphical 
representation of the data from four independent experiments is shown in Figure 3.3B. 
 In summary, we have optimized in vitro transcription conditions for Ac-CoA 
dependent activation of transcription and have used these optimized conditions to verify 
previous observations related to Tax-mediated HTLV-1 transcription activation. 
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Figure 3.3. Histone H3 lysine 14 to arginine mutation is defective for 
activator/coactivator/Ac-CoA dependent transcription activation from the 
HTLV-1 promoter in vitro. A) An in vitro transcription assay comparing the activity 
of a wild-type chromatin template to a mutant H3K14R chromatin template.  
Transcription reaction mixtures contained HeLa nuclear extract and purified 
recombinant pCREB/Tax, pCREB/Tax/p300, pCREB/Tax/Ac-CoA, or 
pCREB/Tax/p300/Ac-CoA as indicated. The recovery standard, RNA transcript and 
size markers are indicated. Relative transcription was calculated by dividing the 
transcript with the recovery standard, with pC/Tax/p300/Ac-CoA activated wild-type 
chromatin transcription set to 100. B) Graphical representation of A. Data is plotted 
as a mean with standard deviation from four separate experiments. The p-value 











4.1  SUMMARY 
 Transcription activation from the human T-cell leukemia virus type 1 (HTLV-1) 
promoter assembled into chromatin is dependent upon the recruited histone 
acetyltransferase (HAT), CBP/p300. Recruitment of CBP/p300 is mediated by the 
cellular transcription factor, CREB and the virally encoded transactivating protein, Tax. 
Strong transcription activation correlates with acetylation-dependent nucleosome 
disassembly and mutation of a single histone lysine residue, histone H3 lysine 14 
(H3K14) disrupts p300 acetylation-dependent nucleosome disassembly and subsequent 
activation of transcription from the HTLV-1 promoter. These findings suggest that 
nucleosome disassembly requires an acetyl-lysine “reader” protein, leading us to 
hypothesize that the recruited p300 bromodomain may play a significant role in 
facilitating transcriptional activation of the HTLV-1 model promoter. We used in vitro 
assembled chromatin templates to assess the ability of a bromodomain deletion mutant 
of p300 to activate HTLV-1 transcription. Compared to wild-type p300, a bromodomain 
                                                 
3 Chapter four describes a study of the p300 bromodomain during HTLV-1 transcription 
activation. Transcription activation by a bromodomain deletion mutant of p300 was 
examined in vitro on two different recombinant chromatin templates containing the 
HTLV-1 promoter. A recombinant, isolated bromodomain of p300, as well as a 
CBP/p300 specific small molecule inhibitor of the bromodomain, were utilized to 
characterize the role of the p300 bromodomain in HTLV-1 transcription activation. I 
performed the following experiments (Figure 4.1E, 4.2B and D, 4.3A-B, and 4.5A-B), Dr. 
Qian Zhang performed the following experiments (Figure 4.1D and 4.2C), and an 
undergraduate independent study student, Julio Flores Servin, performed the following 




deletion mutant of p300 produced a dramatic reduction in HTLV-1 transcription 
activation. Further, the CBP/p300-specific bromodomain inhibitor, SGC-CBP30, 
produced a similar reduction of activation of transcription, suggesting that the p300 
bromodomain is required for gene activation from this promoter. Importantly, p300 
bromodomain deletion or addition of the isolated bromodomain in trans retains recruited 
HAT activity towards the nucleosomal template through its interaction with pCREB and 
Tax, demonstrating that the transcription defect is unrelated to promoter recruitment and 
p300 HAT activity.  
 
4.2  INTRODUCTION 
 CBP/p300 are multidomain coactivator proteins involved in transcription at a 
large number of cellular genes. CBP/p300 coactivator function is generally thought to be 
exerted in two ways: i) through protein-protein interactions between numerous cellular 
transcription factors, coactivators and basal transcription machinery ii) and through 
recruited intrinsic acetyltransferase activity located in the core domain of p300 (see 
figure 4.2A). CBP/p300 interacts with over 400 different proteins and acetylates 
histones as well as non-histone substrates (58, 59, 61, 62). In addition to the above 
mentioned functional domains of CBP/p300, the coactivator proteins possess an 
acetylated lysine binding domain, called a bromodomain. The bromodomain allows for 
further substrate binding specificity and has been suggested to be important for 




 Bromodomains are found in numerous chromatin modifying enzymes and 
function as specific acetylated lysine binding domains. The bromodomain is a 
conserved structure consisting of a left-handed, four helix bundle connected with two 
interhelical loops (119). The loops form a hydrophobic pocket where acetyl-lysine binds. 
Despite bromodomain structure conservation across 61 known human bromodomain 
family members (142), the amino acid residues in the loops vary considerably from 
bromodomain to bromodomain and thus confer substrate specificity to the various 
bromodomain containing proteins (143). It is important to note, however, that the 
bromodomains of CBP and p300 have 96% sequence identity, and are therefore 
presumed indistinguishable in the experiments presented here. 
 HTLV-1 is a human retrovirus that recruits CBP/p300 for transcription activation 
of the integrated provirus from a repressed chromatin state. CBP/p300 is recruited to 
the HTLV-1 promoter through interaction with the serine 133 phosphorylated form of the 
cellular transcription factor CREB, and the viral transactivator protein, Tax bound at the 
viral enhancer elements (Figure 4.1A). At the HTLV-1 promoter, CBP/p300 is thought to 
primarily activate transcription through acetylation of histone tails. This is supported by 
the observation that inhibition of p300 HAT function using a p300 specific inhibitor, Lys-
CoA, resulted in decreased transcription activation from in vitro assembled chromatin 
templates (104). In addition, p300 mediated HTLV-1 transcription activation requires 
recruited p300 HAT activity through the KIX domain of p300, as demonstrated by a 
reduction in transcription activation when recruitment through the KIX domain is blocked 
(72). More recent data has indicated that p300 HAT activity is also involved in the 
removal of HTLV-1 promoter nucleosomes in vivo and in vitro (106, 107), and that 
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acetylation of a single lysine residue on the H3 tail, lysine 14 (H3K14), is required for 
nucleosome disassembly and transcription activation (1) (unpublished data, see 
Chapter 3 Figure 3.3).  
 We initially became interested in the p300 bromodomain as a result of our most 
recent finding that nucleosome disassembly and Ac-CoA dependent transcriptional 
activation from the HTLV-1 promoter required the acetylation of only one residue, 
histone H3, lysine 14. This was unexpected, as we predicted that an accumulation of 
acetylation marks on the histone tails known to have a destabilizing effect on chromatin 
templates (115, 116, 144), rather than the acetylation of a single lysine residue, would 
have a greater effect on transcription activation. The requirement of a specific singly 
acetylated lysine residue suggests that the mechanism of acetylation for the promotion 
of gene activation in this particular context is through the recognition of H3K14ac by a 
bromodomain containing protein. We therefore hypothesized that the recognition of 
H3K14ac by the p300 bromodomain was involved in nucleosome disassembly and 
transcription activation. Using in vitro transcription, immobilized template assays, and 
HAT assays, we have found that the p300 bromodomain is required for Ac-CoA and 
p300-dependent transcription activation. Importantly, the requirement of the 
bromodomain for transcription activation is not related to the initial recruitment of the 
coactivator to the promoter chromatin template, but instead is related to a transcription 
activation event that is downstream of p300 recruitment to the promoter. These results 
are consistent with the p300 bromodomain functioning in H3K14ac recognition, leading 




 4.3  RESULTS 
4.3a  ADDITION OF EXOGENOUS p300 ACTIVATES TRANSCRIPTION FROM 
VARIOUS CHROMATIN TEMPLATES 
 Previous studies that utilized in vitro reconstituted chromatin templates to study 
Tax-dependent HTLV-1 transcription activation have shown varying dependence on the 
addition of exogenous p300 for transcription activation, as compared to recruitment of 
“endogenous” p300 provided by the nuclear extract (1, 48, 72, 104, 105). We were 
interested in the transcriptional activation ability of a p300 bromodomain deletion mutant 
and therefore initially tested the transcriptional activity of pCREB/Tax-mediated 
transcription activation in the presence and absence of exogenous wild-type p300. We 
tested both a linear fragment template and a circular plasmid template containing the 
HTLV-1 promoter assembled into chromatin using the salt deposition method and 
ACF/Nap1 assembly method (140) , respectively (Figure 4.1A). In vitro transcription 
assays were performed as shown in Figure 4.1C. We found that the different chromatin 
templates display a varying level of dependence on the addition of exogenous p300 for 
Tax-mediated HTLV-1 transcription activation. Under our experimentally optimized 
conditions, Tax-mediated transcription activation from a linear fragment assembled into 
chromatin is completely dependent upon the addition of exogenous p300 (Fig 4.1D, 
lane 5). In contrast, Tax-mediated transcription activation from a plasmid template is Ac-
CoA dependent and is enhanced upon the addition of exogenous p300 (Fig 4.1E, lane 
5). In summary, our in vitro transcription system is sensitive to the addition of 
exogenous p300, allowing for a more tailored system to study the function of the p300 




Figure 4.1. p300 activates 
transcription from the 
HTLV-1 promoter. A) A 
representative HTLV-1 
enhancer element (vCRE), 
illustrating pCREB and Tax 
recruitment of p300 through 
the KIX domain. B) 
Schematic of the chromatin 
templates used. The linear 
fragment template is  
biotinylated and contains the 
natural HTLV-1 promoter and 
enhancer elements upstream 
of a 314 nt G-less cassette 
(top). The plasmid template is 
the 3.2 kbp p4xTRE plasmid, 
consisting of tandem 4 
vCREs upstream of a 378 nt 
G-less cassette (bottom). (C) 
Schematic of the steps 
involved in the in vitro 
transcription assay. (D) In 
vitro transcription assay from 
the fragment template 
assembled into chromatin by 
the  salt deposition method. 
(E) In vitro transcription assay 
from the plasmid template 
assembled into chromatin by 




4.3b  A p300 BROMODOMAIN DELETION MUTANT IS DEFECTIVE FOR AC-COA 
DEPENDENT HTLV-1 TRANSCRIPTION ACTIVATION 
 We were initially interested in determining if the p300 bromodomain was involved 
in promoting HTLV-1 transcription activation through recognition and binding of 
acetylated H3K14. We hypothesized that p300 bromodomain interaction with acetylated 
H3K14 would result in the destabilization and mobilization of promoter nucleosomes, 
ultimately activating transcription. Therefore, we predicted that p300 carrying a 
bromodomain deletion would be ineffective at activating HTLV-1 transcription. Using 
linear fragment and circular plasmid templates, we tested the ability of p300Δ1071-1241 
(p300ΔBR) (Figure 4.2A-B) to activate transcription from chromatin templates in a 
activator and Ac-CoA dependent manner. Figure 4.2C shows again that on a linear 
fragment chromatin template, pCREB/Tax/p300 mediated transcription activation was 
Ac-CoA dependent (lane 5). As expected, as wild-type p300 was titrated, transcription 
activation increased (Fig 4.2C, lanes 5-8). However, when p300ΔBR was titrated over a 
500-fold concentration range, it failed to activate transcription from the HTLV-1 promoter 
(Fig 4.2C, lanes 9-18). Figure 4.2D shows that on a circular plasmid chromatin 
template, pCREB/Tax-mediated transcription activation is Ac-CoA dependent (lane 2) 
and the addition of exogenous p300 enhanced Ac-CoA dependent transcription 
activation (lane 3). Unlike the fragment template, titration of wild-type p300 does not 
result in further transcription activation, probably due to the plasmid chromatin template 
already being saturated with both endogenous and exogenous p300 (Fig 4.2D, lanes 3-




Figure 4.2. A p300 bromodomain deletion mutant is defective for Ac-CoA dependent transcription activation A) 
Schematic showing the p300 domains and the location of the bromodomain deletion. B) SDS-PAGE analysis of 
purified, recombinant wild-type p300 and p300ΔBromo. C) In vitro transcription assay utilizing the fragment chromatin 
template to test the transcription activity of the bromodomain deletion mutant of p300 (p300ΔBR). (D) In vitro 
transcription assay utilizing the plasmid chromatin template to test the transcription activity of the bromodomain 




decrease in transcription activation, likely illustrating a competition between 
endogenous wild-type p300 and exogenous p300ΔBr (Fig 4.2B, lanes 6-8).  
 
4.3c  THE BROMODOMAIN OF p300 IS REQUIRED FOR PROMOTER 
RECRUITMENT AND SUBSEQUENT HAT ACTIVITY IN THE ABSENCE OF 
ACTIVATORS 
 Our results are in agreement with a previous study showing that deletion of the 
bromodomain was inhibitory to transcription activation from the IRF-1 promoter (63). In 
that study, the authors stated that the transcription defect was likely due to a disruption 
in p300 interaction with chromatin. A subsequent study showed that p300 interaction 
with chromatin required the bromodomain (145). However, in our system, p300 
recruitment to the chromatin template is facilitated by the pCREB/Tax interaction with 
the KIX domain of p300. To ensure that deletion of the bromodomain did not result in 
impaired recruitment of p300 within our system, we tested the ability of p300ΔBR to be 
recruited to our chromatin template using an immobilized template assay in the 
presence of radiolabeled Ac-CoA. Figure 4.3A shows that in the absence of activators, 
wild-type p300 has HAT activity directed towards the nucleosomal template (lower 
panel) and is recruited to the template, although to a lesser degree than when activators 
are present (lanes 1 and 3). As expected, the bromodomain deletion mutant, is not 
recruited to the chromatin template in the absence of activators and does not have HAT 
activity towards the template (Fig 4.3A, lower panel, lane 2). This difference is not seen, 
however, when wild-type p300 and p300ΔBr are recruited to the chromatin template in 
the presence of pCREB and Tax through their well-established interaction with the p300 
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Figure 4.3. A p300 bromodomain deletion mutant acetylates histones at a faster rate than wild-
type p300. A) The recruitment of wild-type p300 and p300ΔBR to the HTLV-1 chromatin promoter was 
analyzed in the presence and absence of the transcriptional activators, pCREB and Tax, using 750 ng of 
chromatin in an immobilized template assay in the presence of [14C] Ac-CoA. B) wild-type p300 and 





KIX domain (Fig 4.3A, upper panel, lanes 3 and 4). Consistent with their similar 
recruitment to the promoter, both wild-type p300 and p300ΔBR acetylate nucleosomal 
histones in the presence of pCREB and Tax. (Fig 4.3A, lower panel lanes 3 and 4). 
Significantly, this data indicates that the transcription defect we observe from deletion of 
the bromodomain is not a promoter recruitment/HAT defect, but is related to a 
transcription initiation event downstream of promoter recruitment. 
 We noticed that in the presence of pCREB and Tax, p300ΔBR had increased 
HAT activity compared with wild-type p300 acetylation of nucleosomal templates. This is 
likely accounted for by increased recruitment of p300ΔBR to the chromatin template. To 
further assess the enhanced HAT activity of p300ΔBR, we compared the HAT activity of 
wild-type p300 and p300ΔBR towards free histones, which is independent of 
recruitment. Figure 4.3B shows a time course of HAT activity using [14C] Ac-CoA. Both 
wild-type p300 and p300ΔBR acetylated free histones, although p300ΔBR acetylated at 
a faster rate. This observation is consistent with a recent paper showing the 3D 
structure of the core domain of p300 (aa 1048-1664). The authors found that, in addition 
to the previously identified bromodomain, PHD domain and HAT domain, the p300 core 
consisted of an additional, previously unidentified RING domain. Deletion of the RING 
domain resulted in an increase in p300 autoacetylation and p53 acetylation (65). The 
bromodomain deletion construct used in this, and other previous studies (Δ1071-1241), 
encompasses this RING domain.   
 In light of the structural paper, we wanted to target the bromodomain function 
more specifically and avoid confounding results with this newly identified RING domain 
in which deletion may affect HAT activity and thus transcription activity.  
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4.3d  BROMODOMAIN INHIBITION RESULTS IN DECREASED TRANSCRIPTION 
ACTIVATION WITHOUT DISRUPTION OF THE QUATERNARY COMPLEX  
 In an effort to directly analyze the function of the p300 bromodomain, we purified 
the isolated bromodomain (aa 1039-1196), hypothesizing that its inclusion in our assays 
would compete for full length p300 bromodomain binding to acetylated lysines (Fig 
4.4A). We first tested the binding specificity of the isolated bromodomain to our 
chromatin template. Using immobilized chromatin templates assembled with either 
mock or p300 pre-acetylated histones, we show that the isolated p300 bromodomain 
binds only to acetylated chromatin (Fig 4.4B). We then titrated the isolated 
bromodomain in our in vitro transcription system. Figure 4.5A shows that as the isolated 
bromodomain concentration increases, transcription activation decreases, likely through 
a disruption in interaction between the bromodomain that is contained in the full length 
protein and its substrate. Importantly, addition of the isolated bromodomain does not 
result in a disruption of the pCREB/Tax/p300 complex, nor does it affect recruited HAT 
activity towards the nucleosomal template (Figure 4.5B).  
 To further characterize p300 bromdomain function, we obtained a small molecule 
inhibitor of the CBP/p300 bromodomain, called SGC-CBP30. The inhibitor binds to the 
CBP/p300 bromodomain with low nanomolar affinity and is reported to be 40-fold 
selective for the CBP/p300 bromodomain over BRD4 (another cellular bromodomain 
containing protein). There currently are no published reports using this bromodomain 
inhibitor, however the structure of the CBP bromodomain bound with SGC-CBP30 has 
been submitted to the PDB (Figure 4.6A). We tested the inhibitor in our in vitro 
transcription system and found that upon its inclusion, p300 and Ac-CoA dependent 
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Figure 4.4. The isolated p300 bromodomain binds specifically to acetylated chromatin. A) Schematic and B) 
SDS-PAGE analysis of full length, wild-type p300 and GST-tagged p300 bromodomain (aa 1039-1196). C) An 
immobilized template assay was used to determine the specificity of binding of the isolated bromodomain of p300. 
Briefly, histones were acetylated with p300 prior to chromatin assembly by salt deposition. Chromatin was 
assembled, incubated with GST or GST-p300B, and then washed three times prior to the bound fraction being 





Figure 4.5. The isolated p300 bromodomain inhibits transcription activation without disrupting the quaternary 
complex. A) The isolated bromodomain of p300 was added in trans to an in vitro transcription assay. B) An 
immobilized template assay was used to determine if the isolated p300 bromodomain disrupted binding of 
pC/Tax/p300 to the HTLV-1 promoter (quaternary complex). Chromatin was assembled on the immobilized template, 
incubated with pC/Tax/p300 and increasing amounts of GST-p300B or GST in the presence of [14C] Ac-CoA, and 





Figure 4.6. A CBP/p300 specific bromodomain inhibitor reduces transcription activation without dirsupting the 
quaternary complex. A) Crystal structure of the CBP bromodomain bound to the CBP/p300 specific bromodomain 
inhibitor, SGC-CBP30 (deposited into the Protein Data Bank by Filippakopoulos et al, accession code 4NR7). PyMOL 
was used to obtain the structure. The ZA and BC loops making up the hydrophobic acetyl-lysine binding pocket are 
labeled. The inhibitor is shown in yellow. Ribbon structure is shown in the top panel, and surface representation is 
shown in the middle and bottom panels. B) In vitro transcription assay showing p300 and Ac-CoA dependent 
transcription activation inhibited by SGC-CBP30. C) An immobilized template assay was used to determine if the 
CBP/p300 specific bromodomain inhibitor, SGC-CBP30,  disrupted binding of pC/Tax/p300 to the HTLV-1 promoter 
(quaternary complex). Chromatin (1 µg) was assembled on the immobilized template and incubated with p300 either 
in the absence or presence of pCREB , Tax, Ac-CoA and SGC-CBP30. The chromatin templates were washed three 





transcription activation was abolished (Figure 4.6B, lane 7). Again, we wanted to make 
sure that we were not disrupting the pCREB/Tax/p300 complex at the promoter, so we 
utilized our immobilized chromatin template to look at activator and coactivator binding 
in the presence of the bromodomain inhibitor, SGC-CBP30. Figure 4.6C shows that in 
the absence of activators and Ac-CoA, p300 is not recruited to the chromatin template 
(lane 1). In the presence of Ac-CoA only, p300 is slightly bound to the chromatin 
template, likely through its bromodomain (Figure 4.6C, lane 2) and consistent with our 
experiment in Figure 4.3A. In the presence of Ac-CoA and activators, p300 is robustly 
recruited to the chromatin template through its KIX domain (Figure 4.6C, lane 3). 
Importantly, this recruitment is unaffected in the presence of the bromodomain inhibitor, 
SGC-CBP30 (Figure 4.6C, lane 4). The work with the inhibitor, combined with the p300 
bromodomain deletion mutant and bromodomain competition experiments show that the 
bromodomain is specifically involved in HTLV-1 transcription activation and cumulatively 
support that the bromodomain functions in transcription activation beyond just promoter 
recruitment as was previously proposed (63). 
 
4.4  DISCUSSION 
 The work described herein involved extensive optimization of our in vitro 
transcription system (discussed in Chapter 3) that ultimately culminated in adding 
recombinant, full length p300 to the in vitro transcription reaction. We found varying 
dependence on exogenous p300 addition for HTLV-1 transcription activation using two 
different chromatin templates (Figure 4.1). This variability, nonetheless, is in agreement 
with past studies utilizing in vitro assembled chromatin templates to study Tax-mediated 
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HTLV-1 transcription activation. In previous studies using a circular plasmid template 
assembled into chromatin by the ACF/Nap1 method, the activators pCREB and Tax 
were able to utilize endogenous p300 from the nuclear extract for transcription 
activation and showed an enhanced level of activation upon the addition of exogenous 
p300 (72, 104). Alternatively, in previous studies using a fragment template assembled 
into chromatin using drosophila extracts, transcription activation was found to be 
completely dependent upon the addition of exogenous p300 (105), while other studies 
utilizing a fragment chromatin template showed no dependence on the addition of 
exogenous p300, regardless of the chromatin assembly method used (1, 107). The 
work presented here implies that differences in the exogenous p300 dependency for 
transcription activation could be due to the chromatin assembly method used, the 
chromatin template used, and/or the level of endogenous p300 contained within the 
nuclear extract. 
 It has been well demonstrated that HTLV-1 transcription activation involves the 
robust recruitment of the coactivator protein, p300, to the viral promoter. The various 
domains of p300 that have been previously shown to contribute to HTLV-1 transcription 
activation include the KIX domain, the HAT domain, and the CR2 domain (iBiD) (66, 72, 
104). Cumulatively, our data shows that HTLV-1 transcription activation is activator 
(pCREB and Tax), coactivator (p300) and Ac-CoA dependent, demonstrating the 
importance of the previously characterized functional domains of p300 required for 
transcription activation. From the studies described herein, we have identified the 
bromodomain of p300 to be an additional domain required for HTLV-1 transcription 
activation. Importantly, we have extensively shown that the requirement for the 
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bromodomain in transcription activation is not for the initial recruitment of the coactivator 
to the chromatin template. Instead, our data indicates that the p300 bromodomain 
functions in transcription activation at an event post promoter recruitment. 
  Our data further suggests that the p300 bromodomain functions in the context of 
the full length protein through cooperation with other domains of p300, such as the KIX 
and HAT domains. Figure 4.7 directly shows that p300 promoter recruitment via the 
p300 bromodomain is not sufficient for transcription activation, rather transcription 
activation requires p300 recruitment and interaction with pCREB and Tax at the vCREs, 
presumably mediated by the KIX domain of p300 (lane 5 vs lane 11). A possible 
explanation for the requirement of activator mediated recruitment of p300 is that the 
pCREB/Tax interaction with p300 is a more stable interaction than the p300 
bromodomain/acetylated chromatin interaction. Although the p300 bromodomain 
interaction with chromatin has been reported as a stable interaction (64), we find that 
p300 recruitment to the HTLV-1 chromatin template is more robust in the presence of 
activators, leading to increased targeted local concentration of p300 and increased 
histone acetylation, as evidenced by faster migrating histones on a SDS-PAGE when 
activators are present (Figure 4.6C). Another possible theory is that the pCREB/Tax 
interaction with p300 through the KIX domain orients the coactivator in such a way to 
interact with other factors needed for transcription activation (i.e. basal transcription 
machinery).  
 As part of its coactivator function, p300 is known to interact with over 400 
different proteins. Therefore, there are numerous possible p300 bromodomain 
interactions and it is highly probable that there is more than one p300 bromodomain 
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Figure 4.7. p300 mediated HTLV-1 transcription activation requires activators and Ac-
CoA. In vitro transcription was performed using a fragment chromatin template. Wild-type p300 
and p300ΔBR mediated transcription activation was assessed in the presence and absence of 





interaction required for HTLV-1 transcription activation. In our studies, we blocked the 
transcription activation required interaction/s of the bromodomain of p300 using two 
approaches: adding the isolated bromodomain in trans to compete for and block full 
length p300 binding with its binding partner/s, and inhibition of the bromodomain in the 
full length p300 protein by adding a CBP/p300 specific bromodomain inhibitor. We have 
shown that the isolated bromodomain of p300 specifically binds our chromatin 
templates when acetylated, in contrast to Manning et al (64) that only showed 
bromodomain binding to acetylated histones free in solution and not to acetylated 
nucleosomes. Additionally, from the experiment in figure 4.5B, we show that the isolated 
bromodomain specifically binds to our immobilized chromatin template without 
disrupting the quaternary complex. However, from this experiment, we cannot 
determine if the interaction with chromatin is direct or indirect, as both chromatin and 
p300 are acetylated. Similarly, in our in vitro transcription experiment, the isolated p300 
bromodomain could be interacting with acetylated chromatin, acetylated p300, or an 
acetylated protein present in the nuclear extract. Therefore, it is possible that the 
transcription defect we observe when the p300 bromodomain is deleted or blocked is 
due to a disruption in p300 interaction with chromatin, a disruption of a p300/p300 
intermolecular interaction, or disruption in p300 interaction with some other required 
cellular factor. Additionally, whether this unidentified interaction with the p300 
bromodomain is functionally relevant in vivo and whether the p300 bromodomain is 





4.5  MATERIALS AND METHODS 
 
4.5a  PURIFICATION OF RECOMBINANT PROTEINS 
 pCREB was purified as previously described (133). GST and GST-p300B (aa 
1039-1196) were purified as described in (146). His-tagged p300ΔBR was expressed in 
SF9 insect cells and purified as previously described (63). ISWI and Acf1 were 
coexpressed in SF9 insect cells and purified as previously described (140). Xenopus 
histones and octamer were prepared as in (136). Drosophila Nap1 was expressed in 
E.coli and purified according to (140). C-terminally strep-tagged Tax was made using 
site directed, ligase independent mutagenesis to delete the existing C-terminal His6-tag 
and insert a C-terminal Strep 2 tag (WSHPQFEK). Tax protein was purified from E.coli 
using batch strep-tactin chelate chromatography (Strep-Tactin Superflow, Qiagen) 
according to the manfacturer’s instructions, and dialyzed against 50 mM Tris pH 8, 100 
mM KCl, 4 mM MgCl2, 5 μM ZnSO4, 20% glycerol, 2 mM DTT. Wild-type p300 was 
made by inserting the p300 coding sequence (accession number Q09472) between 
BamHI and EcoRI in the baculovirus pVL1393 plasmid. The clone was custom made by 
Genewiz, is codon optimized for expression in SF9 insect cell culture and contains an 
N-terminal His tag and two C-terminal tags, Strep 2 (WSHPQFEK) and FLAG 
(DYKDDDDK) for purification. Insect cell culture and optimization of baculovirus 
expression were performed by Kinnakeet Biotech. The p300 protein was purified from 
SF9 cell pellets using batch strep-tactin chelate chromatography (Strep-Tactin 
Superflow, Qiagen) according to the manfacturer’s instructions, and dialyzed against  
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50 mM Tris pH 7.9, 100 mM KCl, 6.25 mM MgCl2, 10 μM ZnSO4, 20% glycerol, 1mM 
DTT. Nuclear extract from a HTLV-1 negative human T-cell line (CEM) was prepared as 
in (147). 
 
4.5b  DNA IMMOBILIZATION 
 A fragment of DNA containing the HTLV-1 promoter and enhancer elements 
linked to a 313 bp G-less cassette was produced by PCR amplification, using an 
upstream biotinylated primer (5’-GTCTGAAAAGGTCAGGGCC-3’), non-biotinylated 
downstream primer (5’-GGATATATGAGATGAGTAGG-3’) and the -306 HTLV-1 
plasmid as template. The 588 bp PCR product was purified using an Amicon-Ultra 15 
centrifugal filter device, 50K MW cutoff (Millipore). Biotinylated fragment was bound to 
streptavidin coated magnetic Dynabeads (M280, Invitrogen) per manufacturer 
instructions, at 3 µg DNA/100 uL of slurry of Dynabeads. Percent DNA binding to the 
Dynabeads was determined by spectrophotometric analysis at A260 of the supernatant 
after binding, compared to the A260 of the prebound reaction mixture. Immobilized DNA 
was stored in 1X TE buffer (10 mM Tris, 1 mM EDTA) at 4°C. 
 
4.5c  CHROMATIN ASSEMBLY 
 The salt deposition method, previously described in (107), was used to assemble 
chromatin on the immobilized 588 bp HTLV-1 fragment template. When using the 
p4XTRE/G-less template (plasmid template), the ACF/Nap1 assembly system was used 
as described in (104, 140, 148). Chromatin assembly was performed at empirically 
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determined histone:DNA (mass:mass) that gave complete transcription repression in 
the absence of activators/coactivator/Ac-CoA, but was activated in the presence of 
activators/coactivator/Ac-CoA. 
 
4.5d  IN VITRO TRANSCRIPTION 
 In vitro transcription assays were performed as previously described (104, 107) 
under the following conditions. Briefly, 35 fmol of the plasmid chromatin template or 
130-200 fmol of fragment chromatin template was incubated in the presence and 
absence of 33 nM pCREB, 66 nM Tax, and 10 nM p300 and 100 µM Ac-CoA. All 
reactions contained 20-30 µg CEM nuclear extract. In experiment 4.2D, wild-type p300 
and p300ΔBR were titrated from 10-30 nM. SGC-CBP30 was used at a final 
concentration of 10 µM as indicated in experiment 4.5A. Final reaction volumes were 30 
µL in 25 mM Tris, 50 mM KCl, 6.25 mM MgCl2, 10% glycerol and 0.5 mM EDTA. A 
schematic of the order of addition of components and incubation periods is shown in Fig 
4.1.  
 
4.5e  IMMOBILIZED TEMPLATE ASSAY  
 Chromatin assembled on the immobilized HTLV-1 promoter was incubated with 
the recombinant proteins indicated, and 100 µM Ac-CoA as indicated at 30°C, 1200 
RPM for 1 hour in a buffer containing 50 mM Tris, 100 mM KCl, 6.25 mM MgCl2, 1 mM 
EDTA, 20% glycerol, 0.1% NP-40, 5 ng/µL polydA:dT and 2 mM DTT. Reaction 
mixtures were magnetized, the supernatant was removed and the bound fraction 
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washed three times in the buffer conditions just described (- polydA:dT). The bound 
fractions were resuspended in SDS sample dyes and loaded onto 15% SDS-PAGE 
gels. Bound proteins were analyzed by coomassie staining and/or Western blot as 
indicated. 
 
4.5f TIME COURSE HAT ASSAY 
 p300 (167 nM) was incubated with histone octamer (300 nM) at 30°C for 10 
minutes in a buffer containing 50 mM Tris, 100 mM KCl, 6.25 mM MgCl2, 1 mM EDTA, 
20% glycerol and 2 mM DTT. A mixture of [14C] Ac-CoA and non-radiolabeled Ac-CoA 
was added to a final concentration of 100 µM. The reaction mixture was incubated for 
the times indicated and subsequently squelched by the addition of SDS-PAGE dyes. 



















 The studies presented here identified acetylation at histone H3, lysine 14 as a 
key requirement for Nap1 dependent nucleosome disassembly and transcription 
activation. A single lysine to arginine mutation at lysine 14 on the H3 N-terminal tail 
prevented Nap1-dependent nucleosome disassembly from the HTLV-1 promoter 
template. We later showed that this single mutation also decreased 
activator/coactivator/Ac-CoA dependent transcription activation by more than 50%. In 
agreement with the observations just mentioned, lysine to arginine mutation at lysines 9, 
18 and 23 on the H3 N-terminal tail leaving lysine 14 wild-type, in a background of K→R 
mutations at the other N-terminal histone tails, did not affect Nap1-dependent 
nucleosome disassembly or transcription activation, suggesting that acetylation at 
H3K14 is sufficient for nucleosome disassembly and transcription activation. However, 
additional lysines were still available for acetylation by p300 in the H3K14 wt only 
mutant. Therefore, while we have shown that H3K14ac is required, we cannot be 
conclusive in the statement that sole acetylation at H3K14 is sufficient for nucleosome 
disassembly and transcription activation. We would like this to be addressed in future 
studies, described below.  
 Additionally, we have identified another domain of the coactivator protein, p300 
that is required for transcription from the HTLV-1 promoter. The KIX, HAT and CR2 
(iBiD) domains had been previously identified and characterized to function in HTLV-1 
transcription activation (66, 72, 104). The data presented herein cumulate in the 
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discrovery that the p300 bromodomain is an additional required domain for HTLV-1 
transcription activation. We conclusively show that the requirement for the p300 
bromodomain is not out of necessity for recruitment of p300 to the HTLV-1 promoter, as 
p300 is robustly recruited to the chromatin template by the activators, pCREB and Tax. 
Rather, the p300 bromodomain is functioning in HTLV-1 transcription activation post the 
p300-recruited HAT activity. We have yet to determine the exact nature of its function 
and whether this requirement is relevant in vivo. These findings, nonetheless, are 
potentially very exciting as bromodomain proteins are increasingly targeted for 
therapeutic treatment of human disease (149-151). Of most relevance to our studies, a 
BET-family specific bromodomain inhibitor (JQ1) was recently shown to have anti-
tumour and anti-proliferative effects in HTLV-1 infected cells by blocking Tax-mediated 
NF-κB activation (152).  
 Described below are initial approaches and preliminary data for studying the 
above mentioned, adding to the knowledge of not only Tax-mediated HTLV-1 
transcription activation, but potentially the general mechanisms of p300-mediated 
eukaryotic gene activation. 
 
5.1 IS H3K14 ACETYLATION SUFFICIENT FOR NUCLEOSOME DISASSEMBLY 
AND TRANSCRIPTION ACTIVATION? 
 Using mixed octamer chromatin templates containing lysine to arginine mutations 
at sites of acetylation within the histone N-terminal tails, we have found acetylation at 
H3K14 to be required for Nap1-dependent nucleosome disassembly and 
activator/coactivator/Ac-CoA dependent HTLV-1 transcription activation. Our data also 
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suggests that acetylation at H3K14 might be sufficient for Nap1-dependent nucleosome 
disassembly, as a mutant chromatin template containing K→R mutations throughout the 
nucleosome except for histone H3, lysine 14 was permissive to nucleosome 
disassembly. Conversely, the H3K14 only mutant (H3K9,18,23R, H2A/H2B/H4K-R) still 
retained wild-type lysines at positions 4, 27, 36 and 37. Importantly, lysine residues 27, 
36 and 37 have been shown to be acetylated by p300 at the HTLV-1 promoter, in vitro 
(144). Therefore, we cannot definitively claim that acetylation at H3K14 is sufficient for 
nucleosome disassembly and transcription activation. 
  As such, we have cloned, expressed and purified another H3 tail mutant, called 
H3K→R^7 (K4, 9, 18, 23, 27, 36, 37R) to be used in future studies aimed to determine if 
H3K14 acetylation is truly sufficient for Nap1-dependent nucleosome disassembly and 
transcription activation. Another way of approaching this question would be to use a 
preacetylated chromatin template at H3 lysine 14 and perform experiments in the 
absence of Ac-CoA. Preliminary studies have been performed using such a chromatin 
template (Figure 5.1). Neumann et al describes a method used to genetically install an 
acetyl group at site-specific lysines in recombinant histones (153). H3K14ac was made 
using this method, assembled into histone octamer, assembled into chromatin on our 
immobilized HTLV-1 promoter and then tested in Nap1-dependent nucleosome 
disassembly. We found that in the absence of Ac-CoA, a chromatin template containing 
H3K14ac was not permissive to nucleosome disassembly, suggesting that 
preacetylation at H3K14 is not sufficient (Figure 5.1, lane 5). However, preacetylation at 
H3K14 in the presence of Ac-CoA also did not support nucleosome disassembly, as 
compared to a wild-type chromatin template (Figure 5.1, lanes 2 and 6). This result is 
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Figure 5.1. A) Schematic of the N-terminal histone tails in a H3K14ac 
octamer. The lysines located within the H3 tail are indicated, as is the His6 tag on 
the N-terminus. B) Nap1-dependent nucleosome disassembly assay using a 
chromatin template pre-acetylated at histone H3, lysine 14 only. Wild-type or 
H3K14ac octamer was used to assemble chromatin on an immobilized HTLV-1 
promoter by the salt deposition method. The immobilized chromatin template was 
then incubated with pCREB and Tax, p300, Ac-CoA, Nap1 and 146 bp DNA 
(Widom “601” sequence) as indicated. Immobilized templates were washed 3 
times prior to analysis of the bound and supernatant (evicted) fractions by SDS-





suggestive of two things: Either preacetylation is not permissive to nucleosome 
disassembly and the act of acetylation by p300 is required, or the N-terminal histidine 
tag on H3K14ac inhibits nucleosome disassembly. It would not be surprising that a 
histidine tag on the amino-terminus of the histone H3 tail would be inhibitory, as the 
addition of a histidine tag, in principle, turns H3K14 into H3K20. Therefore, future 
experiments utilizing genetically installed H3K14ac should consider cleaving the 
histidine tag. Additionally, it remains to be tested if preacetylation at H3K14 supports 
transcription activation in the absence of Ac-CoA. One might argue that there are other 
functionally relevant targets of acetylation during transcription activation (104). 
However, recent preliminary data suggests that Ac-CoA is needed only prior to nuclear 
extract addition and preinitiation complex (PIC) formation (data not shown).  
 In summary, chromatin templates assembled from the H3KR^7 and H3K14ac 
octamers will be most useful in future studies addressing the sufficiency of acetylation at 
H3K14 for nucleosome disassembly and subsequent transcriptional activation. 
Importantly, these studies would provide us a better understanding of the mechanism of 
Nap1-mediated nucleosome disassembly at the HTLV-1 promoter. 
 
5.2 IS THE REQUIREMENT FOR THE p300 BROMODOMAIN IN HTLV-1 
TRANSCRIPTION ACTIVATION FUNCTIONALLY RELEVANT IN VIVO?  
 We have identified a requirement for the p300 bromodomain during HTLV-1 
transcription in vitro and wish to determine if the same is true in vivo. We propose using 
the CHOK-1 cell line that contains the integrated HTLV-1 promoter driving a luciferase 
gene and performing luciferase assays to measure transcription activation in vivo. The 
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development of this cell line is described in (154) and has been used by our lab in the 
past to study Tax-mediated transcription activation in vivo (106). Importantly, transient 
transfection with a Tax expression plasmid activates transcription from the integrated 
HTLV-1 promoter. To study the effect of blocking the p300 bromodomain on HTLV-1 
transcription activation in vivo, we envision two approaches. The first approach involves 
the inhibition of endogenous CBP/p300, and the second involves first the 
overexpression of p300 (or a p300 bromodomain mutant) and subsequent blocking of 
both endogenous and overexpressed CBP/p300 with either the SGC-CBP30 
bromodomain inhibitor or overexpression of the isolated p300 bromodomain.   
 We have used the first approach involving inhibition of endogenous CBP/p300 
and have performed preliminary in vivo experiments. CHOK-1 cells were seeded and 
transfected with a Tax expression plasmid for 12 hours, followed by a 2 hour treatment 
with the CBP/p300 specific bromodomain inhibitor, SGC-CBP30, prior to cell lysis and 
analysis of cell lysate luciferase activity. We find that treatment with the inhibitor results 
in a modest dose-dependent inhibition of HTLV-1 transcription, in vivo (Figure 5.2A). 
Additionally, we have also performed preliminary experiments involving the second 
approach of overexpressing p300. We obtained a p300 mammalian expression vector 
(pCDNA3.1-p300, Addgene) and cotransfected it with a Tax expression vector, prior to 
performing luciferase assays on cell lysates. Figure 5.2B shows that cotransfection of 
Tax and p300 results in higher HTLV-1 transcription activation than Tax transfection 
alone. As mentioned, future experiments could then utilize the overexpression of a p300 
bromodomain mutant, comparing it to the overexpression of wild-type p300. The 
preliminary experiments presented here certainly require further methods optimization 
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Figure 5.2. A) The CBP/p300 specific bromodomain inhibitor, SGC-CBP30, inhibits Tax 
activation of the HTLV-1 promoter in vivo. CHO-K1 cells were transfected with pSG-Tax and 
treated with the bromodomain inhibitor, SGC-CBP30 for 2 hours just prior to cell lysis 24 hours 
following transfection. Data was normalized to Renilla activity. Averages from triplicate wells are 
represented. B) p300 enhances Tax activation of the HTLV-1 promoter in vivo. CHO-K1 cells 
were transfected with pSG-Tax, pCDNA3.1-p300,  pSG-Tax/pCDNA3.1-p300 or pUC19 as a control. 
Luciferase assays were performed 48 hours following transfection. Data was normalized to Renilla 





as well as replicate measures to determine statistical significance. Lastly, in regards to 
the use of a dominant negative p300 bromodomain mutant, we propose the mutation 
N1132A, based on a recently published report and supported by our own data (65). 
Delvecchio el at made a N1132A mutation in the isolated bromodomain/RING/PHD 
(BRP) of p300 and performed a binding assay with a modified histone peptide array. 
The authors found that the N1132A mutation inhibited almost all binding to acetylated 
peptides. The asparagine at position 1132 directly interacts with the acetyl-lysine in the 
hydrophobic pocket of the CBP/p300 bromodomain (Figure 5.3B). Under my guidance, 
an undergraduate research student (Julio Flores Servin) made this same mutation in 
our isolated p300BRP module and has shown through immobilized chromatin template 
assays and GST-pulldown assays that this mutation disrupts the specific acetyl-lysine 
binding of the isolated p300BRP module to chromatin and p300 (Figure 5.3C and D). As 
such, we are confident in utilizing this mutation as a dominant negative p300 
bromodomain mutant for use in in vivo studies concerning the role of the p300 
bromodomain in HTLV-1 transcription activation. 
  
5.3 IS THE p300 BROMODOMAIN INVOLVED IN PROMOTER NUCLEOSOME 
DISASSEMBLY? 
 As already mentioned and hypothesized, we are interested in whether the 
transcription activation defect caused by deletion or blocking of the p300 bromodomain 
is a defect in promoter nucleosome disassembly prior to PIC formation and transcription 





Figure 5.3. A) Schematic of the domains of p300 and GST-p300BRP. B) Crystal structure of the CBP 
bromodomain, illustrating the location of N1132, colored in green (accession code 4NR7). C) N1132A mutation 
in the p300 BRP module disrupts acetylation-dependent bromodomain binding to the immobilized HTLV-1 
promoter. The HTLV-1 promoter was immobilized, assembled into chromatin by the salt deposition method and then 
subsequently incubated with pCREB, Tax, p300 and p300BRP, p300BRP N1132A and Ac-CoA as indicated. 
Templates were washed three times prior to analysis of the bound fraction by SDS-PAGE and Western blot. D) 
N1132A mutation in the p300 BRP module disrupts acetylation-dependent bromodomain binding to full length 
p300. Purified GST-p300 BRP and GST-p300 BRP(N1132A) were incubated with glutathione-agarose beads, prior to 
incubation with full length p300 in the presence and absence of Ac-CoA, as indicated. The reactions were washed 




 Studying the requirement for the p300 bromodomain in promoter nucleosome 
disassembly during HTLV-1 transcription activation in vivo largely depends upon the 
results described in Chapter 5.2. As such, we would employ whatever methods found 
successful that resulted in a decrease in transcription activation in vivo when blocking 
the p300 bromodomain, prior to performing chromatin immunoprecipitation (ChIP) 
assays to look at histone occupancy within the HTLV-1 promoter region. We would also 
want to ask if histone occupancy correlates with Pol II occupancy, as we have 
previously suggested that promoter nucleosome depletion precedes PIC formation (1).   
To study this in vitro, we could perform the Nap1-dependent nucleosome 
disassembly assay on an immobilized chromatin template, comparing the activities of 
wild-type p300 and the p300 bromodomain deletion mutant (p300ΔBR) in removal of 
histones from the HTLV-1 promoter. We could also perform the Nap1-dependent 
nucleosome disassembly assay in the presence of the CBP/p300 specific bromodomain 
inhibitor, SGC-CBP30 to see if its inclusion inhibits nucleosome disassembly. Other in 
vitro methods that could be used to look at possible differences in the chromatin 
architecture prior to transcription activation include DNase 1 and micrococcal nuclease 
(MNase) digestions.  
 
 
5.4 WHAT IS THE FUNCTIONALLY RELEVANT p300 BROMODOMAIN 
INTERACTION DURING HTLV-1 TRANSCRIPTION ACTIVATION? 
From the studies presented herein, we know that the bromodomain of p300 is 
involved in and required for HTLV-1 transcription activation, as disruption of its binding 
to its binding partner results in decreased transcriptional activation. Naturally then, we 
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next want to know what the functional interaction of the p300 bromodomain is. This is 
perhaps the most important question and the most difficult to answer. Over 400 different 
proteins have been reported to interact with p300 (58). From our studies alone, we 
know that p300 could be interacting with the acetylated chromatin template, 
autoacetylated p300, and/or another acetylated protein provided by the nuclear extract 
during activation of transcription. Mass spectrometry analysis of an immobilized 
chromatin template under transcription activating conditions, in the absence and 
presence of the bromodomain inhibitor SGC-CBP30 might identify a functionally 
relevant interaction. However, this method would not enable us to identify the interaction 
if the target protein is already recruited to the chromatin template through another 
interaction and just not interacting with the p300 bromodomain. To help target the study, 
it might be useful to first incubate immobilized p300 (using either its His, FLAG or Strep 
tags) with a nuclear extract in the presence of Ac-CoA and the SGC-CBP30 
bromodomain inhibitor and then identify by mass spectrometry, nuclear proteins that 
bind to p300 in a bromodomain dependent manner. Regardless of the outcome of the 
above study, we would gain a lot of insight into the identification of acetylated nuclear 
proteins that are recruited to the HTLV-1 promoter during transcription activation, 
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